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Normal spermiogenesis requires the transcription of many genes that occurs 
exclusively after meiosis. This wave of transcriptional changes in haploid 
spermatids is well-documented, but the underlying mechanisms of regulation are 
not. Deficiency of the dual bromodomain-containing protein BRWD1 has already 
been shown to be important for both male and female fertility. Here I show that 
nearly 300 transcripts, most of which are spermatid specific, were downregulated 
in Brwd1-/-mutant testes.  There was nearly complete elimination of transcripts 
encoding proteins important for spermiogenesis, such as the protamines and 
transition proteins. However, the misregulation was not associated with global 
epigenetic changes in chromatin, suggesting that BRWD1 acts selectively upon 
certain haploid-expressed genes. Our collaborators showed that Brwd1 deficient 
oocytes, on the other hand, do not have any differences in transcript levels but 
display a two-fold increase in LINE1 expression. Despite BRWD1’s expression in 
development, infertility is the only clear phenotype in Brwd1 mutants. I found that 
mice doubly mutant for Brwd1 and its paralog Phip were phenotypically 
indistinguishable from Phip-/- mice, indicating perhaps that another paralog, the 
X-linked Brwd3, may be functionally redundant to them in the soma.  !
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CHAPTER 1 
INTRODUCTION 
 
Background and Significance 
In spite of the fact that the world’s population is projected to hit nine billion by 
2050, 15% of couples worldwide remain childless due to fertility defects (Matzuk 
and Lamb 2002). In women the major causes of infertility are ovulation disorder 
or tubal damage accounting for 50% of affected individuals, whereas in men the 
major causes include oligospermia, asthenospermia, teratozoospermia and 
azoospermia which account for 20-25% of infertile men (Hargreave 2000). It is 
now widely accepted that there is a huge genetic component to fertility and as 
many as 2000 genes are known to be involved, for example, exclusively in 
spermatogenesis in humans (Hargreave 2000).  The genetic nature of fertility is 
just beginning to be understood. Scientists have, however, found it increasingly 
difficult to study the genetics of (in-)fertility in human populations (by linkage 
analysis, for instance) due to the inability of probands to transmit mutant alleles. 
To that extent, mouse models have become very useful for studying the genetic 
causes of male and female infertility. 
 
After recognizing these advantages of forward genetics, some labs have 
attempted to screen for phenotypes in mice after subjecting the animals to 
genome-wide mutagenesis (Schimenti and Bucan 1998). ENU (N-ethyl N-
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nitrosourea) was, by then, identified as a potent germline mutagen in mouse and 
was the popular choice for carrying out such large-scale mutagenesis screens in 
many labs (Hitotsumachi, Carpenter et al. 1985, Schimenti and Bucan 1998, 
Kennedy, O'Connor et al. 2005). It is a powerful allkylating agent and causes 
point mutations throughout the genome. The Schimenti lab, in collaboration with 
others at the Jackson lab, started a genome-wide forward mutagenesis screen 
for infertility mutants using ENU as part of the reprogenomics program (Handel, 
Lessard et al. 2006) (Fig 1.1) . One of the novel mutations that arose from this 
infertility screen was called repro5, which was later mapped to the gene Brwd1. 
As will be discussed in detail later, the phenotype of these mutants is unique in 
that seemingly disparate processes of spermiogenesis and oocyte development 
are affected (Philipps, Wigglesworth et al. 2008). 
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Fig 1.1 Reprogenomics Program. Point Mutations were introduced by ENU Mutagenesis in sper-
matogonia of C57B6/J male mice . Mice were then mated to WT C3H females. Through this mating 
scheme, homozygous mutant mice were produced and screened for infertility
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I later showed that Brwd1 is in fact important for the expression of a number of 
post-meiotic genes in the male. This loss of gene expression is not the result of 
changes in global chromatin architecture of round spermatids. To provide context 
to these results, I will describe in depth the molecules that are known to be 
important for the timely expression of post-meiotic genes as well as the global 
epigenetic changes that occur during spermatogenesis in this chapter. Our 
collaboraters showed that in the female, however, BRWD1 does not seem to be 
important for the expression of genes in the oocyte. Instead the retrotransposon 
element LINE1 seems to be consistently over-expressed. Chromosome 
configuration during metaphase and anaphase of meiosis I is also affected. A 
brief review of the process of oocyte development with emphasis on the 
transcriptional regulation of mRNAs and silencing of retrotransposons during 
oocyte growth is provided to better appreciate their results.  I will also describe 
BRWD1 and another dual bromo-domain containing protein BRDT as two 
examples of dual bromo-domain containing proteins that are important for male 
fertility. Brwd1 is expressed all over the mouse, and many of its somatic functions 
seem to be redundant with its paralogs Phip and Brwd3.  In the final part of this 
chapter, I will describe to you what is known about these paralogs. 
 
Transcriptional Regulation in Spermiogenesis 
Mammalian spermatogenesis is a tightly regulated, well-defined process in 
which the male germ line stem cells or spermatogonia differentiate to form sperm 
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in the seminiferous tubules of the testes (Hermo, Pelletier et al. 2010). It can be 
broadly divided into three phases –  
a. An initial proliferation phase, in which the spermatogonia undergo a few 
mitotic divisions preparing for meiosis (Hermo, Pelletier et al. 2010). 
b.  A meiotic phase, in which the cells undergo two rounds of cell-division 
with only one round of DNA replication; thereby becoming haploid (Hermo, 
Pelletier et al. 2010) and 
c.  A differentiation phase, in which the radially symmetrical haploid cells 
(known as round spermatids) undergo massive nuclear and cytoplasmic 
changes, develop polarity and become highly structured gametes. This phase is 
also known as spermiogenesis (Hermo, Pelletier et al. 2010). 
 
The processes that occur during spermiogenesis are unique and do not occur 
anywhere else in the organism. During spermiogenesis, the Golgi secretes and 
stores enzymes that are important for fertilization and eventually transforms into 
an organelle called the acrosome. On the other end, the spermatid develops a 
thickened “mid-piece” surrounded by mitochondria. One of the centrioles in the 
cell, assisted by a temporary structure called the manchette, elongates to form a 
tail. Most of the cytoplasm is eventually lost in the form of residual bodies as the 
spermatids mature. In the nucleus, the chromatin undergoes a significant degree 
of compaction as histones are replaced by transition proteins and eventually by 
more basic protamines. At this stage, all transcriptional activity ceases and the 
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nucleus remains quiescent. The result of spermiogenesis is a sperm - a highly 
structured cell comprising of a head, a mid-piece and a tail. 
 
The incredible morphological changes that occur during spermiogenesis are 
made possible by the expression of unique proteins in the spermatid. The 
expression of these proteins, in turn, is tightly regulated by a wave of post-
meiotic transcription that takes place in the spermatid. (Fimia, Morlon et al. 2001, 
Kimmins, Kotaja et al. 2004, White-Cooper and Davidson 2011) These genes are 
sometimes referred to as the “haploid genome” as the majority of them are 
exclusively transcribed in the haploid round-spermatid stage (Dadoune, Siffroi et 
al. 2004). The importance of the timely expression of these genes is underlined 
by the fact that their absence or untimely expression can cause male sterility.  
For example, haploinsufficiency of the genes encoding protamines, Prm1 and 
Prm2, causes male sterility (Cho, Willis et al. 2001). Similarly male mice deficient 
for ODF1, the main protein of the sperm tail outer dense fibers, are infertile due 
to a variety of defects in sperm (Yang, Meinhardt et al. 2012). Notably, both 
protamines and ODF1 are expressed in the wave of post-meiotic transcription 
that occurs in spermatids.!!In spite of the importance of post-meiotic 
transcriptional regulation, little is known about the key-players of this process in 
mice, as their study has been hampered by the absence of an in-vitro germ-cell 
differentiation model. Therefore almost all of the genes important for post-meiotic 
transcription have been discovered through the study of genetic mouse mutant 
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models (White-Cooper and Davidson 2011). Here I will briefly review some of the 
literature of what is known about post-meiotic transcriptional regulation in mice.!
 
CREM/ACT System of Transcriptional Regulation 
cAMP Response Element Modulator (CREM) and cAMP Response Element 
Binding Protein (CREB) are related proteins that bring about transcriptional 
regulation in response to stresses, metabolic and developmental signals in a 
variety of tissues. They usually respond to signaling pathways affected by the 
secondary messenger cAMP (Hummler, Cole et al. 1994, White-Cooper and 
Davidson 2011). Both CREB and CREM function by binding the cis-element CRE 
(cAMP Response Element), which is characterized by the sequence 5’-
TGACGTCA-3’ or the half-CRE 5’-TGACG-3’ and 5’-CGTCA-3’. While CREB is 
ubiquitously expressed at similar levels across cell-types, CREM displays cell-
specific expression (Foulkes, Borrelli et al. 1991). CREM has many isoforms, the 
majority of which are transcriptional repressors as opposed to CREB, which is 
usually an activator of transcription. One of the most well known isoforms of 
CREM is the repressor ICER (Inducible cAMP early repressor) (Daniel, Rohrbach 
et al. 2000). Activating isoforms of CREM are expressed in some tissues. The 
most well studied of these is CREM-! expressed exclusively in the testis 
(Foulkes, Mellstrom et al. 1992, Daniel, Rohrbach et al. 2000). CREM-! was 
suspected to play a role in post-meiotic transcription as it was expressed only in 
spermatids and many post-meiotic genes carry a CRE element in their promoter 
(Delmas, van der Hoorn et al. 1993, Behr and Weinbauer 2001). The importance 
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of the role of CREM in spermatogenesis, however, only became clear when a 
Crem knock out mouse was created. Male mice deficient in CREM were infertile 
and displayed spermiogenic defects (Blendy, Kaestner et al. 1996, Nantel, 
Monaco et al. 1996). As expected, post-meiotic gene expression was affected in 
these mice (Nantel, Monaco et al. 1996, Beissbarth, Borisevich et al. 2003). 
Many important post-meiotic genes such as protamines, transition proteins, 
ODF1, a few AKAPs, etc. were shown to be de-regulated in the mutant, 
explaining the arrest in spermiogenesis.  
  
Further insight into post-meiotic transcription regulation via CREM came with 
the identification of its co-activator ACT (Activator of CREM in Testis) – a LIM 
domain containing protein that is expressed exclusively in round spermatids 
(Fimia, De Cesare et al. 1999, Fimia, De Cesare et al. 2000)(Fig 1.2). This led to 
the discovery of a novel pathway of CREM activation that was independent of the 
phosphorylation status of CREM, as ACT was able to bind unphosphorylated 
CREM. Interestingly ACT knockout mice were fertile, in spite of some 
abnormalities in their sperm, the ACT knockout did not phenocopy the CREM 
knockout. This indicated that ACT is not required for all of CREM’s functions and 
that other pathways may be involved or other proteins are present in the testis 
that may function redundantly with ACT (Kotaja, De Cesare et al. 2004, 
Lardenois, Chalmel et al. 2009). ACT itself is regulated by the kinesin KIF17b, an 
isoform of the ubiquitously expressed kinesin KIF17 found exclusively in brain 
and testis (Macho, Brancorsini et al. 2002). KIF17b is able to shuttle ACT into 
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and out of the nucleus in a microtubule independent manner (Macho, Brancorsini 
et al. 2002, Kotaja, Macho et al. 2005)(Fig 1.2). KIF17b interaction with ACT is 
dependent upon its phosphorylation status brought about in an as yet 
unidentified pathway that is regulated by Protein Kinase A (PKA). cAMP may, in 
turn, regulate the activity of PKA and this is supported by the fact that 
administration of an adenylate-cyclase inhibitor inhibited KIF17b-ACT interaction 
in-vitro. (Kotaja, Macho et al. 2005). This presents an interesting pathway where 
cAMP can regulate the function of CREM through its action on KIF17b.   
 
KIF17b also interacts with Testis Brain RNA Binding Protein (TB-RBP) and the 
post-meiotic RNAs expressed as a result of CREM activation (Chennathukuzhi, 
Morales et al. 2003). TB-RBP has been shown to be involved in mRNA transport 
and stability. Interestingly, KIF17b was also found to be associated with MIWI in 
the chromatoid body (Kotaja, Lin et al. 2006). MIWI is another protein known to 
be involved in stabilizing mRNPs in spermatids and helping regulate translation 
of these mRNAs, apart from its potential role in piRNA biogenesis (Deng et al, 
2002).  Thus KIF17b may be involved in the transportation of post-meiotic RNAs 
from the nucleus to the cytoplasm bringing them to the well-known RNA 
processing center chromatoid body. Finally, CREM can interact with TFIIA, but 
not with its testis-specific homolog ALF (TFIIA-Like Factor), and bring about 
transcriptional activation (De Cesare, Fimia et al. 2003). 
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Hormones regulate the expression of the activating isoform of CREM in testis. 
Follicle Stimulating Hormone (FSH) brings about the shift in expression from a 
repressive isoform to an activating isoform of CREM in pachytene spermatocytes 
(Foulkes, Schlotter et al. 1993). Higher CREM-! expression, however, is not a 
result of transcriptional activation; instead it is the result of stabilization of CREM-
! mRNA in response to FSH. FSH, through its action on Sertoli cells, is thought to 
bring about these changes in round spermatids through a series of paracrine 
signals. These signals, by an as yet unidentified mechanism, modulate the usage 
of an alternative poly-A adenylation site that is more 5’ in the 3’-UTR of the 
CREM-! isoform. Usage of this poly-A site eliminates several destabilizer 
elements found in the 3’-UTR, thereby stabilizing the activating isoform CREM-! 
(Foulkes, Mellstrom et al. 1992, Foulkes, Schlotter et al. 1993) The mRNAs are 
stored in spermatocytes and are not translated until the round spermatid stage. 
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Fig 1.2 The CREM-ACT Pathway of Post-meiotic Transcriptional Regulation. CREM interacts 
with ACT and activates transcription of post-meiotic genes by interacting with proteins 
within the TFIID complex and ALF. Kif17b is a protein that further regulates this system by 
shuttling ACT in and out of the nucleus. Kif17b itself is regulated by phosphorylation per-
haps by PKA. Kif17b also shuttles the transcribed mRNA out of the nucleus into the chroma-
toid body, where it interacts with MIWI.
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Unique Homologs of Basal Transcription Factors in Spermatogenesis 
Three RNA polymerases transcribe genes in eukaryotic cells – pol I 
transcribes ribosomal RNAs, pol II transcribes protein coding genes and non-
coding genes and pol III transcribes small RNAs (Juven-Gershon and Kadonaga 
2010, Akhtar and Veenstra 2011). These polymerases cannot initiate 
transcription by themselves, and they require basal transcription factors for this. 
Basal transcriptional factors recognize the core promoter around the transcription 
start site and initiate transcription. For example, the basal transcription factors 
important for RNA polymerase II function include TFIIA, TFIIB, TFIID, TFIIE and 
TFIIF. Together with pol II form they form the pre-initiation complex (PIC) 
(Thomas and Chiang 2006). TFIID itself is a complex that contains TBP (TATA-
Binding Protein) associated with 13-14 polypeptides known as TAFs (TBP – 
associated factors) (Thomas and Chiang 2006) TBP binds to a TATA box – a 
specific sequence motif in the promoter of genes and this binding is one of the 
first steps, which initiates the formation of the PIC (Kim, Nikolov et al. 1993, Kim, 
Geiger et al. 1993, Kim and Burley 1994).  
 
Some basal transcriptional factors have been shown to have testis-specific 
isoforms or unique germ-cell specific paralogs both in Drosophila and mice 
(White-Cooper and Davidson 2011).  Here I will provide a brief summary of three 
such factors that are important for murine spermatogenesis and that have been 
implicated in post-meiotic transcription – TBP-like Factor (TLF) (Also called TBP-
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Related factor 2, TRF2); ALF (TFIIA –like Factor) and TAF7L – a testis specific 
homolog of the more ubiquitously expressed TAF7. 
 
TBP-related Factor-2 (TRF2) 
TRF2 is a distant paralog of TBP that is expressed in almost all metazoans 
(Dantonel, Wurtz et al. 1999). It lacks the ability to bind to a TATA box, and is 
implicated in the transcription of some TATA-less promoters (Moore, Ozer et al. 
1999, Rabenstein, Zhou et al. 1999). TRF2 can interact with TFIIA, TFIIB as well 
as with the germ-cell specifc paralog of TFIIA, ALF (Teichmann, Wang et al. 
1999, Catena, Argentini et al. 2005, Kopytova, Krasnov et al. 2006).  The 
function of TRF2 has been extensively studied in different model organisms 
using knockdowns, dominant-negative and null mutants (Dantonel, Quintin et al. 
2000, Veenstra, Weeks et al. 2000, Muller, Lakatos et al. 2001) In almost all of 
the organisms, TRF2 seems to be robustly expressed in oocytes, growing 
embryos and in the testis. However the extent of redundancy with TBP in these 
processes varies with each organism. In Xenopus, for example, TRF2 (and not 
TBP) is important for the transcription of large number of genes in the developing 
embryo (Jacobi, Akkers et al. 2007), whereas in Drosophila, TRF2 mutants show 
impaired spermatogenesis and oogenesis apart from some specific embryonic 
development defects (Kopytova, Krasnov et al. 2006). In mice, on the other hand, 
TRF2 is dispensible for embryonic development but is required for normal 
spermatogenesis (Martianov, Fimia et al. 2001).  
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The Trf2-null mouse phenotype deserves further description as it relates to 
transcriptional regulation in round spermatids. Trf2-null mice are viable and 
healthy, and look morphologically indistinguishable from WT mice, but males are 
infertile. Further analysis showed that spermatogenesis arrests in these mutants 
during the process of spermiogenesis at round spermatid stage. (Martianov, 
Fimia et al. 2001). A few post-meiotically expressed genes including Act were 
down-regulated in the Trf2-/- mice. Crem expression however was unaffected in 
these mice. TRF2, thus, may have a role in the timely expression of a few post-
meiotic genes.  TRF2 was later shown to be important for chromatin organization 
of the spermatid nucleus (Martianov, Brancorsini et al. 2002). The chromo-
center, a structure of dense hetero-chromatin found in round spermatids, 
appeared fragmented in the Trf2/- mice. TRF2, unlike TBP, was shown to be 
associated with both heterochromatin and euchromatin; and thus may have roles 
other than transcriptional activation. TRF2 is also capable of acting as a 
transcriptional repressor by sequestering TFIIA (Chong, Moran et al. 2005, 
Tanaka, Nanba et al. 2007) 
 
 More insight into TRF2’s role in round spermatids came after it was shown tha 
TRF2 interacted with TIPT, a testis specific protein (TRF2-Interacting Protein in 
Testis) (Brancorsini, Davidson et al. 2008) TIPT in turn, can bind HPI"– an 
integral component of the spermatid chromocenter. Thus TRF2 maintains global 
chromatin architecture in round spermatids and may also directly regulate 
transcription of post-meiotic genes. 
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TFIIA-Like Factor ALF 
Another transcription factor homolog that is expressed exclusively in the testis 
and the ovary is ALF or TFIIA-Like-Factor (Han, Xie et al. 2004, Xiao, Kim et al. 
2006). TFIIA is part of the pre-initiation complex that helps RNA polymerase 
initiate transcription. It has been shown to stabilize the TBP binding to the 
promoter and can also recruit various co-activators to facilitate transcription.  In 
the mouse male germ cells, ALF, which is a TFIIA paralog localizes within the 
nucleus in the round spermatid stage (Han, Xie et al. 2004, Xiao, Kim et al. 
2006). Thus, it may play a role in the wave of post-meiotic transcription that 
occurs at this stage. ALF has also been shown to interact with TRF2 (Catena, 
Argentini et al. 2005). It can also functionally substitute TFIIA in cells. ALF is 
regulated by the action of the transcription factor Rfx2 in male germ-cells, which 
in turn is regulated by A-Myb (Horvath, Kistler et al. 2009) 
 
Testis-specific TAFs 
TAFs refer to the TBP-associated Factors that bind TBP and aid in its 
recognition of the promoter. They can directly interact with transcriptional 
activators and they are critical for the recognition of the promoter and selectivity 
of RNA polymerase II.  Interestingly, however, there are many testis-specific 
TAFs that are paralogs of the more ubiquitously expressed counterparts (White-
Cooper and Davidson 2011). Extensive studies of null-mutants of these genes in 
Drosophila have shown the specificity as well as the importance of these 
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paralogs in spermatogenesis. Can (paralog of dTAF5), Nht (paralog of dTAF4), 
Mia (paralog of dTAF6), Sa (paralog of dTAF8) and Rye (paralog of dTAF12) are 
all important for spermatogenesis, and the absence of any of these genes cause 
male infertility (Hiller, Lin et al. 2001, Hiller, Chen et al. 2004). These tTAFs form 
a testis-specific TFIID complex and are thought to activate transcription of genes 
important for spermiogenesis. Alternatively, there is evidence that they may also 
function by re-localizing the repressive Polycomb group of proteins from the 
promoters of spermiogenesis-specific genes into the nucleolus of spermatocytes 
(White-Cooper and Davidson 2011). In mice, TAF4B (a paralog of TAF4) is 
highly expressed both in testis and in the granulosa cells of the ovary. Taf4b 
deficient mice are initially normal, but progressively lose germ cells and this 
results in male sterility by 3 months of age. There is evidence to show that 
TAF4B maybe important for the expression of genes in spermatogonia (Falender, 
Freiman et al. 2005, Oatley and Brinster 2008). 
 
Taf7l is an X-linked paralog of the more ubiquitous Taf7 that is expressed 
highly in testis (Pointud, Mengus et al. 2003); however more recently expression 
in other tissues such as adipocytes, liver, spleen has been reported (Zhou, 
Kaplan et al. 2013). Taf7l is the more ancient paralog of Taf7 that has evolved a 
testis-specific function (Cheng, Buffone et al. 2007). Taf7l null male mice are not 
completely infertile, but give birth to smaller litter sizes. They display a wide 
variety of abnormal sperm that are morphologically defective and have a lower 
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sperm count. Microarray analyses have shown that 6 genes are mis-regulated in 
the mutant (Cheng, Buffone et al. 2007).  
 
Insights from the study of cis-elements 
The study of cis-elements has also provided some insight into the 
transcriptional regulation of post-meiotic genes. Here I will discuss two specific 
examples that have been studied extensively: the promoter of the Sp-10 gene, 
an acrosomal protein and the promoter of the protamine genes. 
 
a. SP-10 gene regulation 
Sp-10 is a post-meiotic gene that is expressed in round spermatids (Reddi, 
Flickinger et al. 1999). It encodes the protein SP-10 that is implicated in sperm-
egg interaction and is part of the acrosome. The Sp-10 promoter has been 
studied quite intensively and the DNA elements important for transcriptional 
activation have been well characterized (Reddi, Flickinger et al. 1999, Reddi, 
Shore et al. 2002, Reddi, Shore et al. 2003, Acharya, Govind et al. 2006, 
Abhyankar, Urekar et al. 2007, Reddi, Urekar et al. 2007).  The -186/-91 region 
upstream of the transcription start site is essential for activation of transcription of 
Sp-10 (Acharya, Govind et al. 2006). An interesting aspect of the Sp-10 promoter 
is that a short sequence of DNA is sufficient for transcriptional activation, as well 
as, for insulating the gene from surrounding chromatin environment. Indeed, the 
Sp-10 promoter sequence and insulator sequence overlapped in a unique 
manner unlike other insulators that are usually separate from the promoter 
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sequences (Reddi, Urekar et al. 2007). Also, the SP-10 insulator did not contain 
CpG di-nucleotides, nor did it possess a CTCF-binding site –hallmarks of 
insulator sequences (Reddi, Urekar et al. 2007). TDP-43 (TAR DNA binding 
protein of 43 kDa size), which is found in the nuclear matrix of round spermatids, 
was shown to bind this insulator region and may function by tethering the 
insulator region to the nuclear matrix (Abhyankar, Urekar et al. 2007). Finally, two 
DNA-binding factors of the NFAT family (Nuclear factors of activated T-cells) 
NF45 and NF90, both of which are expressed in the nuclei of spermatocytes and 
spermatids, was shown to bind to the purine box located in the SP-10 promoter 
and may be important for its transcriptional regulation (Ranpura, Deshmukh et al. 
2008). 
 
b. Protamine Gene Regulation 
The protamine genes are the most well studied post-meiotic genes in mice. 
One of the factors that causes transcriptional activation of the protamine genes is 
TET-1, which was isolated from testis nuclear extracts (Tamura, Makino et al. 
1992). Later, numerous testis-specific and ubiquitous proteins capable of binding 
the Prm1 promoter were discovered including the Y-box binding protein MSY1 
(Zambrowicz and Palmiter 1994, Nikolajczyk, Murray et al. 1995). MSY1 is the 
mouse homolog of the Xenopus germ cell specific RNA/DNA binding proteins 
p54/p56 and is expressed both in oocytes and spermatids in mice. Five different 
protein-binding sites in the protamine promoter – including the CRE element that 
binds CREM, the CAAT box that binds Y-box binding proteins as well as two 
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hormone response elements were later characterized (Ha, van Wijnen et al. 
1997). Interestingly, in a separate study, it was shown that Germ-cell Nuclear 
Factor and CREM-tau regulate protamine expression reciprocally – GCNF acts 
as a repressor whereas CREM-tau acts as an activator (Hummelke and Cooney 
2004). An in-depth analysis of how the “protamine domain” containing the genes 
Prm2, Tnp1 and Tnp2 is regulated by potentiation; the opening up of higher order 
chromatin structures to provide access to transcriptional activators; was 
undertaken by the Krawetz lab (Martins and Krawetz 2007). The protamine 
domain becomes DNAseI hypersensitive as early as the pachytene spermatocyte 
stage, even though transcription does not begin until much later. The 5’ and 3’ 
ends of this domain are attached to the nuclear matrix thus looping the chromatin 
in between them and insulating the region from the surrounding chromatin 
environment (Martins and Krawetz 2007). Histone modifications that favor 
transcription do not appear until spermatid stage. Histone H3 and H4 acetylation 
increase markedly in this domain as the germ cells progress from spermatocyte 
to spermatid stage.  Interestingly, H3K9Me2; a methylation mark important for 
HP1 recruitment does not seem to change much in this region even when the 
gene starts transcription (Martins and Krawetz 2007). 
 
Epigenetic Modifications and Transcriptional Regulation 
Epigenetic modifications broadly refer to the post-translational modifications of 
histone residues as well as the DNA methylation patterns that affect chromatin 
architecture and regulate gene expression. Some of the most common histone 
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modifications include methylation and acetylation of lysine and arginine residues, 
phosphorylation of serine and threonine residues as well as ubiquitylation and 
sumoylation of lysine residues (Godmann, May et al. 2010). These modifications 
play an important role in spermatogenesis and spermatid chromatin 
condensation (Rousseaux, Caron et al. 2005, Godmann, Lambrot et al. 2009).  
Interestingly many histone modification enzymes and histone variants are 
robustly and specifically expressed in male germ cells (Lahn, Tang et al. 2002, 
Hayashi, Yoshida et al. 2005, Akimoto, Kitagawa et al. 2008). Indeed, many 
unique chromatin-remodeling events take place during spermatogenesis 
including establishment of imprinting in PGCs, meiotic chromosomal 
recombination and segregation as well as histone-to-protamine transition in 
spermiogenesis necessitating the use of multiple, testis-specific histone 
modification enzymes (Govin, Dorsey et al. 2010).  Most of the insight that we 
presently have about the role of epigenetic marks in spermatogenesis is from the 
study of transgenic mouse models. 
 
 H3K4 methylation status of the chromatin changes throughout the genome 
during spermatogenesis– with high levels in spermatogonia, followed by down-
regulation in pachytene spermatocytes and partial reappearance in spermatids 
(Brykczynska, Hisano et al. 2010). H3K4Me2 and H3K4Me3 mark sites of active 
transcription (Du, Li et al. 2013). H3K9 methylation, on the other hand, is shown 
to accumulate in the transcriptionally quiescent chromocenter of round 
spermatids and is implicated to be important for the chromatin condensation that 
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follows (Liu, Zhou et al. 2010). The importance and uniqueness of these 
methylation patterns in male germ cells is underlined by the expression of testis-
specific methyl transferases and de-methylases and their stringent regulation. 
Prdm9 is an example of a methyl-transferase specifically expressed in male and 
female germ cells that is important for meiotic gene activation. A Prdm9 knockout 
showed decreased trimethylation and an increase in dimethylation causing mis-
regulated gene expression (Hayashi, Yoshida et al. 2005). Similarly, an example 
of a testis specific demethylase is JMJD1A. Male mice deficient in JMJD1A 
display infertility and an arrest in spermiogenesis. The mutant mice show 
increased H3K9 mono- and di-methylation in spermatocytes and spermatid that 
cause diminished recruitment of CREM on the promoters of its target genes – 
Tnp2, Prm1 and Prm2 (Liu, Zhou et al. 2010). The mutants also display 
decreased ACT expression. Another group showed that JMJD1A binds the 
promoters of the protamine genes directly and de-methylates H3K9 causing 
transcriptional activation (Okada, Scott et al. 2007). Thus, JMJD1A-dependent 
de-methylation of H3K9 may be important for post-meiotic transcription. Little is 
known about the role of other histone modifications in the regulation of post-
meiotic transcription. It is however very likely that epigenetic modifications play 
an important role in post-meiotic gene expression; either by helping to maintain 
global chromatin architecture or by recruiting specific transcription factors to 
promoters of post-meiotically expressed genes. An altered epigenetic landscape 
in round spermatids may prevent loss of repressors from or recruitment of 
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activators to the promoters of post-meiotic genes causing mis-regulated 
expression of genes.  
 
    Bromo-and WD-Repeat Containing-1 BRWD1 
Efforts to characterize Bromodomain and WD-repeat containing-1 (Brwd1) 
began when it was annotated as one of the genes found in the Down-critical-
region-2 of the human chromosome 21, a region that is associated with Down-
Syndrome (Huang, Rambaldi et al. 2003). Brwd1 is expressed in a wide-variety 
of human adult tissues and has several different transcript sizes that have tissue 
specific expression patterns (Ramos, Vidal-Taboada et al. 2002). For example, in 
humans, a shorter 2.6 kb fragment is expressed only in the pancreas, and an 
intermediate 5 kb fragment is expressed only in the liver, whereas a larger 13 kb 
fragment in expressed in heart and skeletal muscle!(Ramos, Vidal-Taboada et al. 
2002). In the mouse however, only one transcript size of about 7.8 kb was found 
by Ramos et al. This transcript is expressed in mouse embryonic development 
from E11 to E18 and in all of the murine adult tissues that were tested – brain, 
kidney, testes, pancreas and muscle. In different human cell-lines, Brwd1 is 
expressed as a 12 kb or a 5 kb transcript depending on the cell-line. In general 
high expression of Brwd1 was found in tissues or cell-lines with a high rate of 
proliferation such as embryos, cancerous tissues and tumor-derived cell lines 
(Ramos, Vidal-Taboada et al. 2002). 
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Huang et al. further characterized Brwd1 expression in mouse (Huang, 
Rambaldi et al. 2003). By performing whole mount in situ hybridizations on 10.5 
dpc mouse embryos, they found robust expression of Brwd1 in the crano-facial 
area, the first branchial arch, the heart and the limb-bud. By 12.5 dpc, strong 
expression was seen in the frontonasal region, prevertebral column and most 
visceral organs like liver, heart, lung and the gastrointestinal tract. However 
unlike Ramos et al., they did not report a signal in the brain or spinal cord. 
Overall, they found a 8.3kb transcript that begins at 7.5 dpc, peaks around 10.5-
11.5 dpc and decreases by 14.5 dpc. They developed an antibody against a C-
terminal epitope of the protein to further characterize its expression. Expression 
of protein was found in a variety of developing embryonic tissue and cell-lines. In 
a co-immuno-precipitation study, BRWD1 was found to precipitate with BRG1 a 
component of the SWI/SNF chromatin-remodeling complex but not with TAF250. 
The poly-glutamine rich region of BRWD1 was shown to possess transcriptional 
activation properties providing even more evidence that BRWD1 can act as a 
transcriptional regulator in some of the tissues (Huang, Rambaldi et al. 2003). 
 
The Schimenti lab discovered Brwd1 as a gene that is important for fertility 
through a forward genetics approach. An allele that rendered both male and 
female mice infertile was discovered through an ENU mutagenesis screen and 
was named repro5. The mutation was later mapped to a donor site on exon 10 of 
the gene Brwd1 (Philipps, Wigglesworth et al. 2008). The aberrant splicing of 
Brwd1 caused exon 9 to splice directly into exon 11, producing a frame-shift that 
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resulted in a premature stop-codon. These aberrant transcripts presumably 
undergo nonsense-mediated decay, and thus the repro5 allele is a null or a 
severe hypomorph of Brwd1. A separate gene-trap allele of Brwd1 failed to 
complement the repro5 allele further indicating that it was absence of BRWD1 
that caused the infertility phenotype. 
 
Brwd1 mutants do not display any other discernable phenotype in spite of 
previous reports of the gene’s wide spread expression in embryonic development 
and mouse adult tissues. Brwd1 mutant ovaries and testes were found to be 
morphologically indistinguishable from the controls (Philipps, Wigglesworth et al. 
2008). The ovaries contained follicles and oocytes at various stages of 
development and corpora lutea were also present. In female mutants, the only 
phenotype observed was defective oocyte development. Only about half of the 
mutant oocytes harvested at the GV stage were capable of progressing to 
metaphase II when subjected to in vitro maturation. Among all of the metaphase 
II arrested mutant oocytes, none were able to cleave to the 2-cell stage or form 
blastocysts, after in vitro fertilization. On the other hand, mutant males had lower 
sperm count and severely abnormal sperm. Most of the sperm isolated from their 
epididymides were immotile or dead as determined by Eosin-Negrosin staining 
(Philipps, Wigglesworth et al. 2008). None were able to fertilize WT eggs. More 
than 90% of the sperm had morphologically abnormal head shapes and sperm; 
and the tails were defective. The mid-piece was “ragged”. The initial stages of 
spermiogenesis however seemed to be normal and the numbers of round 
spermatids were not different from wild type. Malformed sperm heads were 
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evident only in the elongating spermatid stage and were probably caused by 
defective chromatin condensation. A normal acrosome also failed to form. Unlike 
most mutations that cause infertility in both males and females, Brwd1 mutants 
did not have any gross perturbations in the meiotic stages of germ cell 
development. Chromosome synapsis and Double Stand Break processing was 
found to be normal indicated by SYCP3 and yH2Ax staining (Philipps, 
Wigglesworth et al. 2008). Metaphase I and metaphase II spreads also displayed 
normal number and configuration of chromosomes. Thus, absence of BRWD1 
caused defects exclusively in spermiogenesis and oocyte to embryo transition. 
 
BRWD1 contains a dual bromodomain and several WD repeats that form a 
beta propeller structure. Bromodomains are the only interaction modules that 
specifically recognize #-N acetylation of lysine residues (Mujtaba, Zeng et al. 
2007). All known bromodomains fold into a conserved 120 residue structural four 
helix motif identified as a conserved domain in the Drosophila Brahma gene 
(Tamkun, Deuring et al. 1992, Mujtaba, Zeng et al. 2007) (Fig 1.3).  They are 
present in a wide variety of proteins including transcriptional co-regulators, 
chromatin modifying enzymes such as HATs (histone acetyl-transferases), HAT-
associated proteins, ATP-dependent chromatin remodeling complexes, 
helicases, SET domain containing methyl transferases and nuclear scaffolding 
proteins (Yang, Ogryzko et al. 1996, Dhalluin, Carlson et al. 1999, Venturini, You 
et al. 1999, Jacobson, Ladurner et al. 2000, Cavellan, Asp et al. 2006, Gregory, 
Vakoc et al. 2007, Trotter and Archer 2008, Malik and Bhaumik 2010). Although 
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bromodomains exhibit large sequence variations, they share a conserved fold 
that is a left-handed helix bundle of 4 " helices ("Z, "A, "B, "C) linked by diverse 
loop regions of variable length (Fig 1.3). Bromodomains recognize the acetyl 
lysine residue through a central deep hydrophobic cavity. WD-repeats on the 
other hand, are defined by the presence of four or more repeating units 
containing a conserved core of approximately 40 amino acids usually ending with 
Tryptophan-aspartic acid WD (Liu, Sekito et al. 2001) (Fig 1.3). They are 
minimally conserved and are initiated by a glycine-histidine (GH) di-peptide about 
11-24 residues from the N terminus end. All WD-repeats form a circularized $-
structure. WD-repeat containing proteins function in a wide-variety of processes 
ranging from signal transduction and cell cycle to chromatin assembly, RNA 
synthesis and processing, vesicular trafficking etc (Liu, Sekito et al. 2001). The 
underlying common function of all WD-repeat family members is coordinating 
multi-protein complex assemblies by serving as a scaffold for protein interactions. 
Often, they can simultaneously bind to several different proteins. Some examples 
of proteins that contain a WD-repeat structure are the $ subunit of G proteins, 
TAFII transcriptional factor and E3 ubiquitin ligase complexes (Tyers and Willems 
1999). 
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BRDT and the BET family of proteins. 
Another murine testis-specific protein that is similar to BRWD1 in a number of 
different ways, including the presence of the dual bromodomains, is BRDT.  
BRDT is a member of the BET family of proteins characterized by the N terminal 
pair of tandem bromodomains and a unique C terminal ET domain found only in 
this family (Berkovits and Wolgemuth 2013).  The function of BRDT in mammals 
has been well studied and has provided insight into the role of a bromodomain-
containing protein in spermatogenesis.  
 
The first BET gene discovered was in Drosophila; it is called female sterile 1 
homeotic (fs(1)h). Fs(1)h was discovered in a screen for maternal effect mutants; 
it is the only BET family gene found in Drosophila (Florence and Faller 2008). 
Yeast have two BET family genes BDF1 and BDF2 – BDF1 was identified in a 
screen for genes affecting snRNA transcription (Lygerou, Conesa et al. 1994). In 
mammals there are four BET family genes BRD2, BRD3, BRD4 and BRDT; they 
are all expressed in testis (Shang, Salazar et al. 2004). However, they are 
expressed at different time-points, suggesting that they may have non-redundant 
roles in spermatogenesis. BRD2, BRD3 and BRD4 are also ubiquitously 
expressed in a variety of mouse tissues. These genes have a number of 
functions: BRD2 modulates transcription in particular cell cycle induced 
transcriptional activation (Shang, Salazar et al. 2004). It interacts with the 
transcription factors, TBP and E2F (Denis, Vaziri et al. 2000, Peng, Dong et al. 
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2007) and binds to acetylated chromatin in the body of transcriptionally active 
genes aiding in RNA polymerase progression (LeRoy, Rickards et al. 2008).  
BRD4 acts as a transcriptional co-activator as it can bind p-TEFb and acetylated 
histones and can recruit the transcription-complex to promoters of genes poised 
for transcription (Jang, Mochizuki et al. 2005, Yang, Yik et al. 2005, Yang, He et 
al. 2008). BRDT on the other hand is the only BET family gene to be uniquely 
expressed in the testis (Jones, Numata et al. 1997, Taniguchi, Suzuki et al. 2001, 
Pivot-Pajot, Caron et al. 2003). 
 
The first mutant to be created was Brdt!BD1 in which the first bromodomain was 
deleted (Shang, Nickerson et al. 2007). This mutation, when homozygous, 
rendered all male mice infertile with no other discernable phenotype. Sperm from 
Brdt mutant mice displayed a wide-variety of defects including malformed heads 
and tails, very similar to the Brwd1 mutant phenotype. The chromocenter, a 
structure that contains all peri-centric chromatin in the round spermatids, was 
fragmented in the mutants and multiple foci were found (Berkovits and 
Wolgemuth 2011). Interestingly, BRDT protein is not found associated with the 
chromocenter, but rather is found adjacent to it.  The “level of heterochromatin” 
as assessed by staining for HP1alpha in these mutants was also found 
increased, and thus it was hypothesized that BRDT plays a role in chromatin 
architecture by preventing spread of heterochromatin. The impact of the 
chromocenter fragmentation is seen in the elongation phase of spermatids where 
the chromatin is elongated with the help of an actin network to form the sperm 
! '-!
head. H1FNT, which is mis-localized in the BRDT mutants, seems to be 
important for elongation of spermatids (Berkovits and Wolgemuth 2013) 
Apart from playing an important role in maintaining chromatin architecture, 
BRDT plays an important role in regulating gene expression. Microarray studies 
show that a number of genes are mis-regulated in the mutant. About 1000 genes 
were shown to be upregulated and greater than 400 genes down-regulated in the 
mutant (Berkovits, Wang et al. 2012) BRDT also interacts with the spliceosome 
machinery in the testis and 3’ UTR splicing is another mechanism by which 
BRDT regulates post-meiotic gene expression. BRDT’s role in the compaction of 
chromatin during the histone to protamine transition is still under debate 
(Berkovits and Wolgemuth 2013).  
 
  Oocyte Maturation 
Female side of gametogenesis is very different from spermatogenesis in mice. 
Primordial germ cells in the female genital ridge develop into oogonia or female 
germ-line stem cells that are pluripotent in nature (Matova and Cooley 2001). 
Unlike spermatogenesis, where the spermatogonia pool is maintained throughout 
the life of the mouse, in oogenesis, all of the oogonia replicate their DNA and 
enter meiosis (Nakatsuji and Chuma 2001). The oocytes however do not 
complete meiosis and they arrest at prophase I in the diplotene stage. At the 
same time they become intimately associated with somatic cells known as 
granulosa cells, thus forming follicles (Matova and Cooley 2001). Hormones in 
the circulating blood of the female mouse then govern the subsequent 
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development of the oocyte and its release from this arrest. Follicle Stimulating 
Hormone (FSH) stimulates batches of follicles to develop – the oocyte starts 
growing in size and enters the growth phase as the granulosa cells also grow in 
number and develop (Richards and Pangas 2010). The granulosa cells start 
secreting large amounts of estradiol into the circulation. Accumulation of estradiol 
triggers a surge in the level of another hormone in the blood stream– the 
Luteinizing Hormone (LH) (Shepel, Blashkiv et al. 2012). The LH surge 
stimulates further growth of the follicle, finally releasing the oocyte from its 
prophase I arrest – the oocyte completes meiosis I, forms the first polar body and 
re-arrests at the metaphase II stage (Shepel, Blashkiv et al. 2012). During this 
process of oocyte meiotic maturation, it is ovulated from the ovary and is 
released from its surrounding somatic cells (Richards 2005). The oocyte is, 
however, maintained in this metaphase II arrest until egg activation upon 
fertilization with sperm. 
 
The term “oocyte maturation” is loosely used to describe the various changes 
that take place in the primary oocyte during its growth as a result of which it 
acquires developmental competence for fertilization (Masui and Clarke 1979). A 
number of changes occur in the oocyte as it matures. It makes specific sperm 
receptors, accumulates nutritional reserves for the embryo, acquires competency 
to be activated after fertilization, hence allowing formation of the zygote; for 
example by equipping itself for mechanisms that prevent polyspermy (Voronina 
and Wessel 2003). Finally, the nucleus of the oocyte undergoes tremendous 
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changes – it enters meiosis and re-arrests at metaphase II. All transcription 
ceases when the oocyte re-enters meiosis, and the chromatin assumes a more 
condensed configuration during this transition in mammals (Voronina and Wessel 
2003). Oocyte maturation thus comprises both nuclear maturation and 
cytoplasmic maturation.  
 
Changes in Chromatin Configuration and Transcription during Oocyte 
Maturation 
Transcription in the oocyte is tightly regulated in mice; it begins in the enlarged 
nucleus of the primary oocyte (called germinal vesicle) as it enters the growth 
phase (Bachvarova and Paynton 1988). At this stage, the chromosomes assume 
a mostly decondensed and dispersed configuration that allows access to various 
transcription factors. Transcription ceases as the oocyte begins to mature – this 
is also correlated with the corresponding condensation of the chromosomes, 
breakdown of the germinal vesicle and dispersal of nucleoli (Masui and Clarke 
1979). Homologous chromosomes then align along the meiotic spindle and 
separate and the oocyte extrudes the first polar body as it completes maturation. 
Only after fertilization, at the 2-cell stage, is transcription activated again in 
mouse.  
 
The changes in chromatin configuration can be observed visually in antral 
stage follicles. At this time, the GV staged oocytes (oocytes that have not 
undergone germinal vesicle breakdown (GVBD) i.e. not re-entered meiosis) are 
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of two possible chromatin configurations as they mature from NSN oocytes (non-
surrounded nucleolus stage) and to SN oocytes (Surrounded nucleolus stage). 
Visibly these oocytes can be differentiated by the presence or absence of a 
Hoechst-positive rim surrounding the nucleolus. In the SN staged oocytes, this 
rim is present, whereas in the NSN oocytes it is absent (Tan, Wang et al. 2009). 
Interestingly these chromatin configurations are associated with different 
transcriptional states. When Br-UTP was injected into oocytes, in an in-vitro 
transcription run-on assay, only NSN oocytes (and not SN oocytes) showed high 
levels of fluorescence indicating that transcription was silenced in the SN oocytes 
(Bouniol-Baly, Hamraoui et al. 1999) (Fig 1D). The visible changes that are seen 
in this transformation from NSN to SN oocytes can be attributed to the change in 
localization of transcriptionally silent heterochromatin. In both NSN and SN 
oocytes, the centromeres co-localize with AT rich heterochromatin; but in the 
NSN oocytes they are localized in spots near the nucleolus, whereas in the SN 
oocytes they cluster around the nucleolus to form a compact ring (Longo, 
Garagna et al. 2003). Attainment of the SN-configuration is important for the 
oocytes to be able to develop to the metaphase II stage – only 20-30% of the 
NSN oocytes are able to develop to metaphase II and those that do reach 
metaphase II, arrest at 2-cells stage after fertilization. Taken together, this means 
that the NSN oocytes have lower developmental competence than the SN 
oocytes (Ma, Li et al. 2013).  Transcriptional silencing however seems to be 
independent of the formation of SN chromatin configuration. In mice deficient for 
nucleoplasmin (Npm2-/-) the oocytes cannot form the SN-configuration; but 
! '(!
transcriptional silencing occurs at the right time (De La Fuente, Viveiros et al. 
2004). Instead, oocyte-somatic cell interaction seems to be important for the 
timely occurrence of the transcriptional silencing (De La Fuente and Eppig 2001). 
 
Histone modifications also seem to play an important role in the changes of 
chromatin configuration that occur in GV stage-oocytes (Xia, He et al. 2012). The 
profile of DNA methylation, histone methylation and acetylation increases 
quantitatively throughout folliculogenesis until the oocyte becomes fully-grown 
and has entered the SN stage (De La Fuente, Viveiros et al. 2004). In particular 
acetylation of H3K9, H3K18, H4K5 and H4K12 increases with oocyte growth 
(Kageyama, Liu et al. 2007). The fully-grown oocyte now undergoes germinal 
vesicle breakdown. Coincident with this, a massive wave of deacetylation occurs. 
Chromatin is re-acetylated only after fertilization (Kim, Cheon et al. 2003, Longo, 
Garagna et al. 2003). An interesting protein with chromatin remodeling activity 
called ATRX is found associated with the perinuclear heterochromation in SN 
oocytes. ATRX belongs to the SNF2 family of helicases and ATPases  (De La 
Fuente, Viveiros et al. 2004). In spite of the genome wide deacetylation that 
occurs at GVBD, ATRX remains associated with the centromere and may be 
important for the proper separation of chromosomes in anaphase I (De La 
Fuente, Viveiros et al. 2004).  
 
All the processes after oocyte growth, including meiotic maturation, fertilization 
and early embryo development completely depend on the pool of mRNAs that 
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was transcribed during the growth phase. Oocytes regulate these processes by 
translational control of the pool of RNAs present in the cell. An important process 
that occurs during this time is the dramatic degradation of select maternal 
transcripts (Su, Sugiura et al. 2007). Paradoxical as it may seem, that the oocyte 
would degrade about 20% of the RNAs that it made during the growth phase, this 
event is necessary for the oocyte to embryo transition. A few important proteins 
(such as MSY2) have been implicated in maintaining the stability and the 
translational regulation of the stored mRNAs (Medvedev, Pan et al. 2011).  
 
Similar to spermatogenesis, oocytes also transcribe many unique genes, 
different isoforms of ubiquitously expressed genes and paralogs of other somatic 
genes. For example, oocytes use different paralogs of the basal transcriptional 
machinery. One such factor is TRF2 that substitutes for the function of TBP in the 
oocyte nucleus. Even though both TBP and TRF2 can mediate transcription in 
oocytes, TBP seems to be dispensible for oocyte maturation and remarkably its 
nuclear concentration seems to decrease with oocyte growth (Gazdag, 
Santenard et al. 2009). Another TAF paralog that is important for both oocyte 
maturation and spermatogenesis is TAF4b. While in male mice TAF4b seems to 
be important for spermatogonial proliferation, in females it seems to play a 
variety of roles. TAF4b null females have fewer oocytes and they arrest after 
fertilization. Only 45% of the oocytes are able to re-enter meiosis and they have 
defective spindles (Falender, Shimada et al. 2005). ALF is a paralog of TFIIA that 
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was discussed in depth before that is also uniquely expressed in oocytes 
(DeJong 2006). 
 
Apart from modulating transcription, oocytes also have to maintain genomic 
integrity and protect their DNA from disruptive factors such as retrotransposon 
activation (Zamudio and Bourc'his 2010). Indeed several retrotransposons are 
robustly expressed in mammalian oocytes and active mechanisms to degrade 
them are present (Piko, Hammons et al. 1984, Park, Shin et al. 2004, Peaston, 
Evsikov et al. 2004).  Dicer seems to play an important role in checking the 
expression of these transposons (Murchison, Stein et al. 2007). Dicer knockout 
mice are unable to complete meiosis and arrest with defects in meiotic spindle 
organization and chromosome congression. They also have up-regulated 
expression of many transposons (Murchison, Stein et al. 2007). Another mutant 
with mis-regulated retrotransposon expression is the Marf1 knockout. Marf1 
mutant oocytes have a variety of defects including up-regulated expression of 
transcripts, defective cytoplasmic maturation, meiotic arrest and up-regulated 
expression of IAP and LINE1 retrotransposons, as a result of which they are 
ovulated without germinal vesicle breakdown. (Su, Sugiura et al. 2012) 
  
Paralogs of BRWD1  
BRWD1 has two highly similar paralogs in mammals – PHIP (Pleckstrin 
homology Interacting Protein) and BRWD3. Both paralogs contain the WD-40 
repeats as well as the dual bromodomains at essentially identical positions and 
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they share about 60% amino-acid identity and 73% similarity over most of the N-
terminal. They are also expressed ubiquitously in tissues similar to Brwd1 and 
hence may have redundant functions with BRWD1. Indeed, in spite of the 
ubiquitous expression of BRWD1, a null mutant of Brwd1 is only infertile 
(Philipps, Wigglesworth et al. 2008). Insight into the importance of the Brwd 
family of genes comes from genetic mutants in invertebrates such as Drosophila 
that have only a single brwd gene. Several different mutant alleles of this gene 
have been created in Drosophila, the most severe of which, an allele called 
ramshackle, is lethal (D'Costa, Reifegerste et al. 2006). The brwd gene in 
Drosophila seems to have a variety of functions in different tissues and only a 
few of these functions have been unearthed. Apart from playing important roles 
in the development of photoreceptor cells in the retina, it was recently shown that 
the brwd gene in Drosophila is a DDB1-CUL4 associated factor that recruits a 
cullin4 RING finger E3 ligase to ubiquitylate the Drosophila CRY gene, an 
important event for re-setting the photoperiod in flies (Ozturk, VanVickle-Chavez 
et al. 2013).  
 
Pleckstrin Homology Interacting Protein - Phip 
Phip was originally identified as a 100kDa cytoplasmic protein through yeast 
two-hybrid screening of proteins that interact with the PH domain of the Insulin 
receptor substrate-1 (IRS-1) (Farhang-Fallah, Randhawa et al. 2002). It was 
further shown that PHIP is required for insulin receptor mediated mitogenic and 
metabolic signal transduction. Later another novel isoform of Phip of 206kDa size 
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was isolated from mouse pancreatic islet cells and was called Phip1. PHIP1 is 
nuclear and seems to be involved in the control of beta-cell proliferation and 
survival and can function both in an IGF-1 dependent and independent manner 
(Podcheko, Northcott et al. 2007).  A deeper insight into the function of the Phip 
gene came from a genetic knockout. Phip deficient mice show 40% growth deficit 
at weaning compared to litter mates.  They develop hyperglycemia and live for an 
average life span of just 4-5 weeks. Phip deficient mouse embryonic fibroblasts 
grow markedly slower than WT fibroblasts, but exhibit normal AKT 
phosphorylation and increased proliferation in response to IGF1, indicating that 
this pathway was intact (Li, Francisco et al. 2010).  
 
Brwd3 
BRWD3 was first identified as a factor that played a role in STAT92E mediated 
transcription, as dsRNA that targeted BRWD3 strongly suppressed it (Muller, 
Kuttenkeuler et al. 2005). Later it was shown that mutations in this gene 
interacted with the JAK/STAT pathway in Drosophila. Further studies confirmed 
that BRWD3 is in fact a positive regulator of the Drosophila JAK/STAT pathway 
(Arbouzova and Zeidler 2006). The human homolog of Brwd3 is X-linked and is 
disrupted in a large proportion of individuals with B-cell chronic lymphocyte 
leukemia (Kalla, Nentwich et al. 2005). It was also shown that mutations in this 
gene in human causes X-linked mental retardation associated with macrocephaly 
(Field, Tarpey et al. 2007). 
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   CHAPTER 2 
METHODS 
 
RNA Extraction from Testis  
RNA was prepared from whole testes of WT and mutant mice using Trizol and 
purified using RNeasy columns. Briefly, the testes from each mouse were 
homogenized in 700ul Trizol and total RNA was extracted using 140ul 
chloroform. The aqueous phase was then separated by centrifugation and 525ul 
of 100% ethanol was added to it. This phase was then directly loaded onto a 
Qiagen RNeasy mini column and purified according to the manufacturer’s 
instructions. 
 
Microarray Analysis 
 RNA extracted from WT and mutant testes were analyzed for quality using 
BioAnalyzer. They were then converted to biotin labeled cRNA fragments 
according to the protocols described by Affymetrix. Hybridization was performed 
using Affymetrix MOE430 2.0 gene chips that represent more than 39000 
uniquely expressed murine transcripts. Washing and scanning were also done 
according to Affymetrix protocols. The signals from scanning were analyzed 
using Affymetrix GCOS software. The normalized signals were then analyzed 
using R software using a standard t-test and genes were considered up- or 
down-regulated if they showed > 2 fold difference in expression with a p value of 
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< 0.01. Genes were classified as meiotic, post-meiotic or somatic using the 
BioMart mining tool available at the germonline.org database. 
 
Real Time PCR  
cDNA was prepared from freshly extracted RNA from WT and mutant testes 
using Superscript III Reverse Transcriptase as per manufacturer’s instructions. 
10ul of a 1:100 dilution of the above reaction was used as template in a 25ul 
master-mix using 2X SYBR-green. Primers were designed for select genes of the 
microarray using Integrated DNA Technologies RealTime PCR Tool such that the 
product sizes were 150bp. Primer sequences are listed in the table below. Non-
specific amplification was tested for using dissociation curve analysis in the Real-
Time PCR software. Ct values for the different reactions were noted and fold 
enrichment was calculated as the ratio of 2Ctmut/2CtWT. 
 
Table 2.1 Real-Time PCR Primer Sequences 
 
 
 
 Gene  Forward Primer Sequence Reverse Primer Sequence 
1 Tnp1 GGGCGATGATGCAAGTCGCAATTA TCACGACTGGCATTTACCCACTCT 
2 Tnp2 AAGTGAGCAAGAGAAAGGCCGTCA ACATCCTGGAGTGCGTCACTTGTA 
3 Prm1 AGACTTCAAGAGCATCTCGCCACA ACAGGTGGCATTGTTCCTTAGCAG 
4 Prm2 TGCAGGAAATGTAGGAGGCACCAT AGGGCTCAGACATCGACATGGAAT 
5 Akap4 ACGGGCCATTTGGATTACCAGAGA TTGCCACTCCTGAGGGAGAATGTT 
6 Hsp1a TTCCTTTATCCAAGCCGTAGGCGA AGGTGTCATCGCAGGACTCAATGT 
7 Tssk6 TGCTGTTGGGTTCTGATTCCTCCT AGGCGCAATGCTTCTCTCTCTTCT 
8 Fscn3 TGGCCTGCTAATGGCAAATGTCAC TGGCGACAGGGCAATAGCTGAATA 
9 Oxct2a AGGTGCTGCTAAGGATGTCCAGTT ACCTCAAGCCCATGCAGCAGATTA 
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Flow Cytometry Analysis 
 A single cell suspension for flow cytometry analysis was prepared as per the 
method described by the Fouchet lab (Bastos, Lassalle et al. 2005). 
Seminiferous tubules were dissociated using enzymatic digestion with 
collagenase Type I for 25 minutes at 32oC in Hank’s Balanced Salt Solution 
(HBSS) (20 mM HEPES (pH7.2), 1.2 mM MgSO4.7H2O, 1.3 mM CaCl2.2H2O, 
6.6mM sodium pyruvate and 0.05% lactate). This was then filtered through a 
40micron nylon mesh. Tubules were collected from the mesh and incubated 
again at 32oC for 25 minutes in HBSS. This was again filtered to remove cell 
clumps. The cells were then spun down and washed with HBSS. The final pellet 
was re-suspended in HBSS, and the cell count determined using a 
hemocytometer. The cells were than fixed in 70% ethanol for 24 hours at 4oC. 
The fixed cells were then washed with 50ug/ml propidium iodide (PI) and 100 
ug/ml Rnase in PBS. Cells were then diluted to a final concentration of 1 million 
cells/ml and analysis was performed using a FACSCalibur4 flow cytometer 
(Benton Dickson Biosciences). PI was excited by a 360 nm ultraviolet laser 
(100mW) and the emitted red fluorescence was detected with a 630nm/30nm 
band passfilter. The emitted fluorescence was proportional to DNA content and 
three distinct populations were observed in the fluorescence area vs 
fluorescence width plot.  These populations corresponded to “haploid”, “diploid” 
and “tetraploid” cells in the suspension. The cells in these three distinct 
populations were counted and this was plotted in a Counts vs Fluorescence  
graph. 
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Antibody Production 
Chicken Anti-sera and antibody-rich yolk from chicken injected with a C-
terminal epitope of BRWD1 was provided to me when I joined the lab.  I purified 
antibody from the serum using the AminoLink Plus Immobilization Kit (PIERCE) 
and from the egg yolk using the EggCellent Chicken IgY Purification Kit 
(PIERCE). I tested the activity and specificity of these antibodies using a 
standard dot-blot assay. Briefly the antigenic peptide and an unrelated peptide 
were blotted at various concentrations on a nitrocellulose membrane. The 
membrane was then blocked using 15% non-fat dry milk and later probed with 
the purified antibody at various dilutions (final concentration of 0.1-10ug/ml) . 
After multiple (3-5) washes with Tween-TBS (TTBS) of 5 minutes each, the blot 
was probed with a secondary anti-chicken antibody conjugated to HRP (1:1000). 
This blot was then washed again (3-5 times of 5 minutes each) with TTBS and 
developed using ECL substrate. The intensity of the “dots” that developed as a 
result of antigen-antibody interaction was a score of the activity of the antibody. 
The antibody was termed “specific” if it did not react with the unrelated peptide. 
 
Later, I developed antibodies against epitopes that I designed. Epitopes that 
were 14-15 amino acids long were used for antibody production against BRWD1. 
About 15 such epitopes with good antigenic score were designed using the 
online tool EMBOSS antigenic. The antigenicity of these peptides was further 
verified by calculating their Surface Probability scores as described by Emini et 
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al. (Emini, Schleif et al. 1985) using the PROTEAN tool of DNAstar Lasergene 
software. They were then checked for cross-reactivity with the paralogs PHIP 
and BRWD3 by a simple BLAST analysis. The following peptides had a high 
antigenicity score, with low cross-reactivity, and were used for antibody 
production: CTDNTQTQRKKKRK, RRNNIYELNPHKEPC and 
DSDGGAVREKSYSNC. These peptides were manufactured and used for raising 
antibodies in New Zealand White Rabbits by Pacific Immunology.  Briefly after 
injection of the animals with the peptides coupled to an adjuvant, blood serum 
was collected after 4 months and its peptide-specific reactivity tested by ELISA. 
The serum was then affinity purified and then re-tested by ELISA. Antibodies that 
showed peptide specific activity were then shipped to us. I further validated the 
specificity and reactivity of the antibodies to the antigenic peptides using the dot-
blot assay described above. 
 
Preparation of TAP-Tagged BRWD1 using BAC Recombineering 
As my efforts to develop a working antibody against BRWD1 were 
unsuccessful, I decided to epitope tag the gene in the N-terminal and C-terminal 
and create a transgenic mouse. TAP-tag (Tandem affinity purification tag) was 
my choice for epitope-tagging. TAP-tagged proteins can be pulled down and 
eluted in native conditions that allows for the purification and identification of 
native protein complexes by mass spectrometry (Gloeckner, Boldt et al. 2007). 
The SF-TAP tag that I used was as described by Gloeckner et. al. 2007, and is a 
4.6 kDa tag that combines a Strep-tag II and FLAG tag in tandem.  
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I attempted to insert the TAP tag into both the N-terminal as well as the C-
terminal of Brwd1 by BAC-recombineering using the modified DH10B strain 
SW102 that uses a galK positive/counterselection cassette as described by 
Soren Warming (Warming, Costantino et al. 2005).  
 
 Cloning of FLAG-BRWD1 into pCAGGS vector 
A vector pdream2.1(CMV)FLAGBRWD1 containing the complete BRWD1 
sequence with a FLAG tag was purchased from Genscript. FLAGBRWD1 was 
then amplified from this vector using BIO-X-ACT Long DNA polymerase and 
cloned into a pCAGGS expression vector using the enzyme XhoI. Clones were 
verified by sequencing. 
 
Cloning tcp10 promoter into pdream2.1(CMV)FLAGBRWD1 
A full length Tcp10-bt promoter was amplified from constructs described in the 
paper by Ewulonu et al. (Ewulonu, Buratynski et al. 1993). The promoter was 
cloned into the pDREAM2.1(CMV)FLAGBRWD1 using the enzymes FseI and 
PacI. Tcp10 promoter was cloned upstream of FLAG BRWD1 and replaced the 
CMV, p10 and T7 promoters in the original pDream2.1(CMV)FLAGBRWD1. 
Clones were sequenced and verified. 
 
 
 
! ()!
Preparation of Transgenic Mice from pdream2.1(tcp10)FLAGBRWD1 by 
Pronuclear Injection 
A sequence-verified pdream2.1(tcp10)FLAGBRWD1 clone (3 ug of plasmid 
DNA) was digested by enzymes XmaI and MluI to create a linear fragment of 
FLAGBRWD1 driven by tcp10 promoter. This was then purified from a low-melt 
agarose gel without using a DNA-chelator dye such as ethidium bromide using 
the QIAquick gel extraction protocol. The gel-purified DNA was eluted in Injection 
buffer (10 mM Tris, pH 7.5, 0.1 mM EDTA, 100 mM NaCl). About 2ul of gel-
purified DNA was run on an Et-BR stained gel and quantified roughly by running 
a marker of known concentration in parallel. The DNA was diluted to a 
concentration of 3 ng/ul for micro-injection. In the meantime, donor females 
(FVB/n strain) were primed with 2.5 IU PMSG and after 48 hours superovulated 
with 2.5 IU Human Chorionic Gonadotropin (hCG). On the day of superovulation, 
about 10 females were set up for mating with males. The next day, all females 
were sacrificed and embryos collected onto M2 medium (Millipore). After 
screening embryos for the prescence of pronucleii, DNA was micro-injected into 
the male pronucleus of each embryo. About 109 embryos were microinjected, but 
only 72 survived after microinjection. The embryos were cultured overnight to the 
2-cell stage. Only about 54 embryos survived to the 2-cell stage, and all surviving 
embryos were transplanted into 4 recipient pseudo-pregnant female mice (2 CD1 
strain and 2 B6D2F1 strain). After pups were born, founder mice were screened 
by genotyping for the insert. The following primers were used for genotyping: 
brwd1L: GTCCGATGCTGGATAAGGAG and 
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brwd1R:AACCATGTACCGCTGAGGTC. Prescence of a 500 bp PCR product 
confirmed successful integration of the FLAG BRWD1 construct. 
 
Preparation of Transgenic mice from pdream2.1(tcp10)FLAGBRWD1 by 
ES cell Injection Method 
pdream2.1(tcp10)FLAGBRWD1 was digested into a linear fragment containing 
(tcp10)FLAGBRWD1 with a neomycin resistance marker. This was then used to 
transfect ES cells (from C57BL/6J albino strain from JAX) by electroporation and 
stable ES-cell clones were made by growing them under neomycin selection. 
Transfected ES cells were karyotyped to check for any abnormal chromosome 
configurations. Briefly cells were grown until they were 50-80% confluent and 
colcemid stock added at a concentration of 20ng/ml. They were then incubated at 
37oC for 30 minutes in an incubator after which they were trypsinized and 
pelleted. The cells were then resuspended in 100ul PBS, and 0.075 M KCl was 
added drop by drop until the final volume was 7 ml. This was then incubated for 6 
minutes in a 37oC water bath. Cells were spun down, and resuspended in 100ul 
PBS and 2 ml of freshly made ice-cold fixatve (3:1 Methanol:glacial acetic acid)  
was added. The resulting suspension was incubated in ice for 1 hour at 4oC. The 
fixing step was repeated twice with 30-minute incubations on ice and finally the 
pellet was resupsended in 500 ul fixative. The final suspension was dropped from 
shoulder’s length onto an ic-cold slide placed at a 45o angle and the slides were 
allowed to dry for 5-10 minutes. Finally the slides were stained in Giemsa 
(GIBCO Karyomax Cat#`00092-021) dissolved in Gurr’s Buffer (0.004M 
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Phosphate Buffer pH 6.8). The slides were washed three times in water and 
allowed to dry. These slides were then observed under a light microscope and 
any abnormalities in chromosome number and configuration was noted. ES cell 
clones with no abnormalities were then used for injection into blastocysts that 
were then transferred into the uterus of pseudo-pregnant female mice of 
C57BL6/J strain. Three rounds of injection were done out of 4 chimeric mice 
were identified by coat-color. Chimeric pups that contained the insert were mated 
with WT females (C57Bl6/J background), and their litters genotyped for presence 
or absence of (tcp10)FLAGBRWD1. The following primers were used for 
genotyping by PCR: brwd1L: GTCCGATGCTGGATAAGGAG and 
brwd1R:AACCATGTACCGCTGAGGTC. Presence of a 500 bp PCR product 
would confirm germline transmission of the construct. 
 
Transient Transfection of HEK cells. 
The pCAGGS-FLAG-BRWD1 plasmid was then transfected into HEK cells 
transiently using TransIT-LT1 reagent from Mirius as per manufacturer’s 
instructions. Briefly about a million freshly grown HEK cells were plated on a 10 
cm plate, 24 hours before transfection. 2.5ug of plasmid DNA was added to 
250ug Opti-MEM I Reduced Serum and mixed gently. 7.5 ul of TransIT-LT1 
Reagent was added to the DNA mixture and the solution was incubated for 15-30 
minutes at room temperature. The DNA-TransIT-LT1-Opti-MEM mixture was 
then added on top of the semi-confluent HEK cells. The cells were then grown at 
37oC for 72 hours to allow for expression of protein. Transfection Efficiency was 
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judged by co-transfecting with vector that expressed mCHERRY protein. Cells 
expressing mCHERRY were easily identified as those cells that fluoresced red 
under a fluorescent microscope. 
 
 
Immuno-staining of Transfected Cells. 
 
HEK cells transiently transfected with pCAGGS-FLAG-BRWD1 were 
trypsinized, washed and re-suspended in 1% paraformaldehyde for 3 minutes. 
After pelleting at 360 g for 3 minutes, the cells were fixed again in 1% PFA for 3 
minutes. 1-10 million cells were then transferred into a chamber-slide and 
washed three times with PBS. After the final wash, PBS was replaced with 
blocking solution (2.5% goat serum, 2.5% donkey serum, 1% BSA, 2% gelatin, 
0.1% Triton X100), and then treated with 0.1% Triton X 100 separately for an 
hour for nuclear permeabilization. The blocking solution was then replaced by 
Rabbit anti-FLAG antibody (Abcam ab124462) at a final concentration of 10ug/ml 
and incubated overnight at 4oC. Next day, the cells were washed 4 times with 
PBS for 5 minutes each and then incubated with secondary antibody (Alexa Flour 
488 anti Rabbit CY5) at a dilution of 1:80 for 20 minutes in dark at room 
temperature. After washing 4 times with PBS for 5 minutes each, the cells were 
mounted on slides with mounting medium that contained DAPI, which stained for 
the nuclei. These slides were observed under a fluorescent microscope. 
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Sub-cellular Fractionation and Western Blotting 
Transiently transfected HEK cells were harvested and fractionated as per 
Mendez J and Stillman B et al, 2000 (Mendez and Stillman 2000). Briefly, about 
10 million cells were harvested, washed thoroughly with PBS and then 
suspended in Buffer A (10mM HEPES, pH 7.9, 10mM KCl, 1.5mM MgCl2, 0.34M 
sucrose, 10% glycerol, 1mM DTT and protease inhibitor cocktail). Triton-X-100 
was then added to a final concentration of 0.1% and the cell suspension was 
incubated on ice for 8 minutes. The suspension was then centrifuged at 1300g to 
separate the nuclear fraction (P1) from the cytoplasmic fraction (S1). S1 was 
further centrifuged at 20,000 g at 4oC to collect a clarified supernatant free from 
debris.  P1 on the other hand, was washed thoroughly with buffer A and lysed for 
30 minutes using Buffer B (3mM EDTA, 0.2mM EGTA, 1mM DTT and protease 
inhibitor cocktail). The lysed fraction was then centrifuged at 1,700 g for 5 
minutes at 4oC, separating the supernatant from the pellet. The pellet contained 
the chromatin, whereas the supernatant contained the nucleoplasmic fraction. 
The chromatin fraction was further washed once with Buffer B and then re-
suspended in SDS sample buffer, ready to load in a poly-acrylamide gel. 
 
Protein samples were thus prepared and 15ul loaded onto a 6-15% gradient 
polyacrylamide gel. After sufficient separation, as judged by the running of a 
marker in parallel, the gel was dislodged from the electrophoresis apparatus and 
the proteins were transferred onto a nitrocellulose membrane overnight at 40V. 
The next day, the blot was blocked using 15% milk for 1 hour and then incubated 
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overnight again with a FLAG antibody at a final concentration of 2ug/ml (Abcam 
ab124462). After thorough washing with Tween-TBS (5 times of 5 minutes each), 
the blot was incubated with an anti-rabbit HRP conjugated secondary antibody 
that was diluted 1:2500.  The blot was washed again thoroughly with Tween-TBS 
(5 times of 5 minutes each) and then probed with ECL substrate. An X-ray film 
was exposed to the blot for 1 minute in the dark and developed and scanned. 
The blot was then later stripped and re-probed for either fibrillarin (a nuclear 
marker) or GAPDH (cytoplasmic marker) similarly. 
 
In-vitro Transcription of FLAG-BRWD1 
I linearized pdream2.1FlagBrwd1 by digesting with Not1 enzyme. I then purified 
it using a standard sodium acetate-ethanol precipitation, and the precipitated 
DNA was resuspended in RNase free water to a final concentration of 1 ug/ul. I 
used 2 ug of linearized DNA as template for an in-vitro transcription reaction 
using mMESSAGE mMACHINE kit (Ambion). The reactions were set-up and 
RNA purified as described in the kit. I then performed a poly-A tailing reaction to 
the transcribed Flag-Brwd1 mRNA using a poly(A) tailing kit (Applied 
Biosystems). The reactions were performed and RNA purified and quantitated as 
described in the kit.  
 
Microinjection of transcribed FLAG-Brwd1 mRNA into oocytes 
Female mice of C57B6/J background were primed with an injection of 5 units of 
PMSG followed by 5 units of hCG 24 hours later. They were then sacrificed 
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around 12-14 hours later. Microinjection was performed exactly as described in 
the protocol by Paula Stein 2009, Cold Spring Harbor Protocols. I injected about 
6 million molecules of RNA into each oocyte.  
 
Immuno-staining of microinjected oocytes for expressed FLAG-Brwd1 
After microinjection of Flag-Brwd1 mRNA into the oocytes, the oocytes were 
cultured for 24 hours in an incubator at 37oC to allow for expression. The oocytes 
were then washed twice for 5 minutes with PBS containing 2% tritonX-100. They 
were then fixed in fresh fixing solution for 30 minutes at 37oC (0.1 M PIPES, 5 
mM MgCl2, 2.5 mM EGTA, 0.5% Triton X-100, 2% Formaldehyde). After a brief 
wash in 0.1% Goat Serum for 15 minutes, the oocytes were transferred to a 
blocking solution containing 10% Goat Serum for 1 hour at 37oC.  A rabbit Anti-
Flag Antibody (Abcam) was then applied to the oocytes at a final dilution of 
1:100. The oocytes were then washed in 10% goat serum for 1 hour at 37oC, 
after which they were transferred into a 5% goat serum solution containing FITC 
anti rabbit secondary antibody (1:80 dilution) for 1 hour at 37oC. The oocytes 
were then washed again in 10% goat serum for 1 hour at 37oC, after which they 
were mounted on slides containing mounting medium with DAPI. They were then 
observed under a fluorescent microscope. 
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In-Situ Hybridization 
Testes were frozen in Optimal Cutting Temperature Medium (OCT) using dry 
ice and cryostat sections were cut at a depth of 15 um. They were then fixed with 
4% PFA in PBS for 10 minutes at RT and washed 3X with PBS. After fixation, the 
slides were incubated in 0.1 M triethanol amine “acetylation solution” for 10 
minutes at RT followed by three washes with PBS. The probe was applied at a 
concentration of 200-400ng/ml in hybridization buffer on the slides and incubated 
at 65oC overnight in a humid chamber. Probe sequences are available on 
request. The slides were then washed for extensively using 0.2X SSC at 65C. 
After cooling, the slides were blocked with blocking buffer (10% sheep serum, 
0.2% Block Reagent from Roche in TBS). The buffer was then replaced with 
alkaline-phosphatase conjugated sheep anti-digoxigenin antibody (1:500) in 
blocking buffer, and incubated overnight at 4 C. This was washed 3X with TBS 
for 10 minutes and then for 5 minutes using Buffer 3 (0.1 M Tris, 0.1 M NaCl, 50 
mM MgCl2, 2 mM levamisole) and finally incubated with 1X NBT/BCIP solution at 
room temperature for 1 hour. Appearance of a blue color corresponding to the 
hybridized RNAs was monitored using a dissecting microscope. 
 
Squash Preps and Immuno-staining 
Testes were dissected from 2 month-old adult WT and mutant testes and the 
albuginea was removed. Seminiferous tubules were eased out and cut into little 
10micron pieces using microscissors. The tubules were than placed on a 
Superfrost Plus slide (FisherBrand) and squashed using a glass cover slip, 
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releasing the germ cells onto the slide. The slides were either frozen at -80oC or 
used directly for immunostaining. 
 
Blocking solution containing 10% goat serum and 0.1% Tween was added 
directly on top of the cells for 1 hour. The slides were then incubated overnight 
with multiple dilutions of primary antibodies (1:50, 1:250 and 1:500) with a PBS 
negative control.  They were then washed next morning 3X with PBS for 10 
minutes and then incubated with corresponding secondary at 1:80 for 20 minutes 
in the dark. This was washed again 3X with PBS and mounted with medium 
containing DAPI and observed under a fluorescence microscope. 
 
Germ Cell Separation – Isolation of Round Spermatids and Spermatocytes. 
Round spermatid and Spermatocyte fractions were prepared from a single cell 
suspension using unit gravity sedimentation exactly as outlined by Wykes et al. 
2003 (Wykes and Krawetz 2003). The cell separation steps were done using a 
CELLSEP apparatus designed by Du Pont Company (SORVALL products).  
 
Dnase I Hypersensitivity Assay. 
The method I describe here is based of the unique protocol described by Martins 
et al. 2007 (Martins, Platts et al. 2007). In this protocol, Martins et al. describe 
how to track chromatin changes around the protamine domain by treating it with 
varying concentrations of DNase I and then amplifying the digested products 
using real-time PCR. Dnase I treatment and whole nuclei of germ cells were 
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prepared from a single cell suspension (either germ cell suspension prepared 
from testes or fractionated spermatid or spermatocyte fraction) using the protocol 
described by Sambrook and Russell Cold Spring Harbor Protocols 2006. Briefly 
about a million to 100 million cells were resuspended in 1.5 ml of ice cold lysis 
buffer (0.05% v/v saponin, 200 mM beta mercaptoethanol, 100 mM KCl, 50 mM 
Tris-CL (pH 7.9), 50% (v/v) glycerol, 5 mM MgCl2) for about 15 minutes on ice.  
The resulting suspension contained lysed cells but intact nuclei. 10 ul of the 
nuclei preparation was tested using a Trypan Blue staining. Intact nuclei stained 
blue. The nuclei were then recovered from the lysed cells by centrifuging at 
1300g for 15 min at 4 C. The pellet was then washed in 1.5 ml ice-cold buffer A 
(50 mM Tris-Cl (pH 7.9), 3 mM MgCl2, 0.2 mM PMSF, 100 mM NaCl, 1 mM 
Dithiothreitol) and then resuspended in 4 ml of buffer A. DnaseI (Worthington) 
solution of 10 Units/ul was serially diluted (1:40 to 1:2560) in Dnase I dilution 
buffer (10 mM HEPES-KOH (pH 7.9), 30 mM CaCl2, 30 mM MgCl2, 50% (v/v) 
glycerol).  180 ul of the nuclear suspension was aliquoted into single tubes and 
this was then treated with the serially diluted Dnase I solute for 20 minutes at 37 
C. The reactions were terminated by the addition of three separate aliquots of 
16.6 ul of 0.5 M EDTA with vortexing. 12 ul of RNase solution (10 mg.ml Rnase A 
in TE Buffer) was then added to the individual aliquots followed by incubation at 
37 C for 30 minutes. Finally 40 ul of proteinase K solution (0.2 mg/ml proteinase 
K in 50 mM Tris-Cl (pH 7.9) and 100 mM NaCl) was added along with 100 ul of 
SDS buffer (20 mM Tris-Cl (pH 7.9), 70 mM EDTA (pH 8.0), 100 mM NaCl, 2% 
(w/v) SDS) and the tubes were incubated overnight at 50 C. The digested DNA 
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was then extracted using a standard phenol-chloroform method and 
resuspended in 50 ul TE buffer. The quality of digestion was checked by running 
samples on a 1% agarose gel. The resulting aliquots were then diluted 1:100 for 
a real-time PCR with primers designed across the hypersensitive sites on genes.  
The real-time PCR was done as described previously. 
 
Chromatin-Immunoprecipitation Assay 
Germ-cell suspension and spermatocyte and spermatid fractions were made as 
described previously. Cells were fixed with formaldehyde at a final concentration 
of 1% (v/v) for 10 minutes. After washing twice with PBS, the cells were then 
lysed with 1 ml SDS-Lysis Buffer (1% SDS, 10 mM EDTA, 50 mM Tris-HCl 
pH8.1) and sonicated such that DNA were broken into fragments that were 500-
1000bp in length. After saving 10% of the fixed cells as input, I centrifuged the 
sonicated suspension at 20,000 g for 15 minutes at 4 C to pellet all the cell 
debris. Before immunoprecipitation, this suspension containing chromatin was 
pre-cleared with Protein A beads (Millipore). The pre-cleared chromatin was then 
incubated with antibodies against the epigenetic marks H4K16Ac, H3K9Me2 and 
H3K9/14Ac (1-2 ug each/vial) overnight at 4 C. This suspension containing a 
mixture of chromatin fragments and antibodies was then incubated for 2-4 hours 
with a 50% solution of protein A agarose bead slurry. This was centrifuged at a 
speed of 4000 rpm to remove the supernatant, and the pelleted beads were 
washed with 1 ml of wash buffer (0.1% SDS, 1% TritonX-100, 2mM EDTA pH 8, 
150 mM NaCl and 20 mM Tris-HCl pH 8) and 1 ml of final wash buffer (0.1% 
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SDS, 1% TritonX-100, 2 mM EDTA pH 8, 500 mM NaCl, 20 mM Tris-Hcl pH 8). 
The bound chromatin was then eluted at 65oC by incubating the beads with 5ul of 
elution buffer (10 mM Tris pH 8, 1 mM EDTA and 1% SDS) for 10 minutes. The 
beads were then spun down and discarded.  120 ul of elution buffer was further 
added to the eluted chromatin to make a final volume of 170 ul, which was then 
incubated at 65oC overnight.  The next day, 150 ul of a proteinase K mix (1 X TE 
Buffer, ph 8, 10 mg/ml glycogen, 20 mg/ml proteinase K) was added to each tube 
and incubated for 2 hours at 37oC. The DNA was then extracted using a standard 
phenol-chloroform extraction method and suspended in 30 ul of RNase TE (0.3 
ug/ul RNase A in TE buffer). This solution was then incubated at 37oC for 2 hours 
and the DNA purified using a standard QIAquick PCR purification kit. The DNA 
was then amplified using a Whole Genome Amplification Kit (Sigma) according to 
manufacturer’s instructions. After amplification, a PCR was done with primers 
designed across the protamine domain. The primers are listed in table. The 
distance from transition start site of Prm2 gene is listed against each primer set. 
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Table 2.2 Primer Sequences along Protamine Domain used for ChIP-qPCR 
Region Primer Sequence  Distance from Prm2 
TSS (0kb) 
A AL:CCATGAAGCCTGTATCACAT 
AR:AAAAGGAGAGGGAGTTGTAGT 
 
-20.4 kb  
B  BL:CAAATTGGGACTCTATTGAGG 
BR:TGTAACTGACGTTTCATGTGAC 
 
-8.2 kb  
C CL: CCACAGACGGCACAACT 
CR:AGTGAGTAGATATGTGCGGATG 
 
-6.5 kb  
D DL:TCCTGGTCCTCTTTGACTTCATAAT 
DR:ATCTGCTCCTGCTTTTGCTG 
 
-5.2 kb 
E EL:LGCGGAGGAGGCGAAGTAAGT 
ER:AGCCCTTCCCATTTGACCAGT 
 
-4.9 kb 
F FL:GAGGCCATCTCACATTCAATA 
FR:GCTCCTCATTCGGTAGCG 
-0.6 kb 
G GL:ATGCAGGTGCAGGAAATGTAGGAG 
GR:AGCTCAGGGCTCAGACATCGAC 
0 kb 
H HL:CCACACCCACCAGTCTCACA 
HR:CTCTCTTGCTTTTCGGGCTCC 
0.7 kb 
I IL:AATCGGCCCAGCTATATAACTAGG 
IR:CACTGGTTACTGGTGTGACTTTGA 
2.9 kb 
J JL:GTGTCCATTTGATCCCAA 
JR:AAAGCTGCTGACTCAAGACTA 
3.6 kb 
K KL:AGGGGAGGAGGCGTGTCAGC 
KR:TTCTCTTTTCCGGCAAGTCTT 
5.8 kb 
L LL:TTAAGTGGGGGGCGCCTTATTA 
LR:CCTGAGAGGTGGGGATGAGGTC 
7.4 kb 
M ML:GCTCTAATTTTCCACCTAACA 
MR:CCAGACTGTGCTCCATAAG 
18 kb 
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Creation of Phip knock-out mice 
Phip knock-out mice were created by micro injecting ES cells containing the 
ene trap RRJ571 (Baygenomics) into C57BL/6J blastocysts. The chimeric mice 
male founders were crossed to C57BL6/6J females to generate F1 heterozygous 
(Phip+/-) mice.  These F1 heterozygotes were then mated with each other to 
create Phip-/- mutants. All genotyping was done using PCR as described in Li et 
al. 2010 (Li, Francisco et al. 2010). 
 
Mating Scheme to produce double mutants 
For creating mice that were doubly mutant, Brwd1+/- mice of C3H background 
were mated to Phip+/- in a mixed C57BL/6J-129 background to create doubly 
heterozygous mice Phip+/-,Brwd1+/-. The double heterozygotes (now in a mixed 
C3H-C57BL6/J-129 background) were than mated with each other in order to 
create doubly mutant Brwd1-/-;Phip-/- mice. Pups were collected either at wean-
age or 2 days after birth and genotyped by PCR. Timed matings were also 
performed and embryos collected from plugged females after either 12.5dpc or 
18.5dpc. Embryos were fixed with 4% paraformaldehyde and genotyped. Double 
mutants were homozygous for both Phip and Brwd1 mutant alleles as identified 
by PCR. Phip genotyping was done using PCR as described in Li et al. 2010 (Li, 
Francisco et al. 2010). Brwd1 genotyping was done by amplifying the fragment 
containing the mutation from genomic DNA by PCR and then sequencing the 
PCR product.  
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CHAPTER 3 
 
RESULTS 
 
Brwd1Gt fails to complement Brwd1repro5/repro5 mutation. 
 
In order to confirm if the observed infertility phenotype was indeed due to the 
Brwd1repro5/repro5 mutation, I created Brwd1Gt mutant animals that contained a 
mutation in the Brwd1 gene as outlined in the methods section. Brwd1Gt/+ 
heterozygotes were crossed to Brwd1repro5/+ heterozygotes to create Brwd1Gt/repro5 
compound heterozygotes and their phenotype was evaluated. 
Similar to the Brwd1repro5/repro5 homozygotes, the compound heterozygotes were 
infertile. The seminiferous tubules of these animals contained fewer spermatozoa 
than controls and the spermatids exhibited a wide variety of abnormally shaped 
heads and acrosomes (Fig 3.1). The epididymal sperm count was reduced > 5 
fold. The sperm displayed poor motility with morphological abnormalities similar 
to Brwd1repro5/repro5 homozygotes (Table 3.1). Sperm count was ~3 fold lower than 
controls.  The proportion of abnormalities in the Brwd1Gt homozygotes however 
was lower than the Brwd1repro5 homozygotes. This maybe because the genetrap 
allele may not be a complete null or that the introduction of the 129-strain 
background suppresses the phenotype slightly. Overall, however, the Brwd1Gt 
allele does not complement the Brwd1repro5 mutation, confirming that a mutation 
in the Brwd1 gene is responsible for the observed infertility phenotype. 
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Fig 3.1 Testes Histology of Genetrap mice. Testes were sectioned and stained with PAS. A. Wild-type B. 
Brwd1repro5/Gt C. Brwd1 Gt/Gt In both panels B and C, a marked decrease in the number of sperm is 
seen. Sperm heads in panels B and C also look morpholgically defective.
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Table 3.1 Sperm count of Genetrap mice and Percentage of Abnormal Sperm 
 
Animal. 
No 
Genotype Sperm/ml % Abnormal 
Sperm 
1 Gt/+ 1.0x106 4% 
2 +/+ 1.3x106 8% 
3 Gt/+ 9.0x105 11% 
 Average 1.0x106 7% 
4 repro5/Gt 2.0x105 98% 
5 repro5/Gt 1.7x105 97% 
 Average 1.85x105 81% 
6 Gt/Gt 3.3x105 81% 
7 Gt/Gt 1.9x105 86% 
8 Gt/Gt 4.5x105 95% 
 Average 3.2x105 87.3% 
 
Haploid genome transcription is disrupted in Brwd1-deficient testes. 
Since BRWD1 contains bromodomains typically associated with acetylated 
histones, I hypothesized that BRWD1 is involved in chromatin remodeling 
required for proper transcription in post-meiotic spermatids and maturing 
oocytes. To test this hypothesis, I performed microarray-based gene expression 
profiling of 27-day old WT (N=4) and mutant (N=4) testes.  At this stage, the first 
wave of germ cells has progressed to the elongating spermatids stage. In the 
mutant, 286 transcripts were decreased by at least two fold compared to WT, 
while 11 transcripts were over-expressed (Fig 3.2). Nine of the most affected 
transcripts were tested by quantitative real-time RT-PCR (qRT-PCR), validating 
their mis-expression. In contrast, none of 11 potentially over-expressed genes 
were validated by real-time PCR. Transcript levels of most of the under-
expressed genes were decreased more than four-fold; a few of them such as the 
protamines and transition proteins were decreased as much as thirty fold.  To 
exclude the possibility that the lower transcript levels observed in mutants might 
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be due to a decrease in elongated spermatids in Brwd1-/- testes, or a delay in 
meiotic progression, two experiments were performed. First, I isolated germ cells 
from both WT and mutant testes, stained them with propidium iodide, and 
analyzed the populations by flow-cytometry.  The amount of fluorescence was 
proportional to the DNA content of the cell, enabling us to quantify the relative 
proportions of “1C” (haploid spermatids), “2C” (primarily diploid spermatogonia) 
and “4C” (primarily spermatocytes).  In 27-day testes, there was no significant 
difference in the proportion of haploid “1C” cells between WT and the mutant (Fig 
3.2). Second, selected transcripts in 21-day old WT and mutants testes were 
compared by qPCR analyses (primarily Prm1, Tnp1 and Tnp2 – all of which are 
mix-expressed in the microarray).  Significant differences in expression were also 
apparent at this time point, which is when the first round spermatids normally 
appear (Fig 3.2).  Because there were no differences in % of haploid spermatids 
between WT and mutant, and the expression differences were apparent 
immediately at the post-meiotic stage, this further argues that the expression 
differences were not due to a delay in meiosis or postmeiotic development.!!
These data suggest that BRWD1 is required for proper expression of genes in 
spermatids.   
! *'!
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Fig 3.2 Expression of genes involved in spermiogenesis is a!ected in Brwd1 mutants. A. Heat Map 
Comparison of gene expression in 27-day old Brwd1+/- heterozygous mice (H1to H4) vs 27-day old 
Brwd1-/- mutant mice (M1 to M4). Expression levels are denoted by color – Bright green indicates no 
or very low expression to bright red standing for highest expression. B. Di!erences in Expression 
Levels are veri"ed by an independent real-time PCR experiment for a few candidate genes. C. Semi-
quantitative PCR shows very little expression of the most-down-regulated genes Prm2, Tnp1 and 
Tnp2 in the mutant testes. D. Real-Time PCR performed on RNA extracted from 21-day old testes 
shows di!erences in expression already. E. Flow Cytometry Analysis of the Cells based on ploidy 
shows that there are no di!erences in the number of “IC”, “2C” and “4C” cells in the mutant testes
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To test whether BRWD1 is required specifically for haploid gene expression, we 
classified the mis-expressed genes as being meiotic (spermatocyte specific), 
post-meiotic (spermatid specific), somatic (Sertoli cell specific) or mitotic 
(spermatogonia specific) using data from a comprehensive characterization of 
differentially expressed genes in the testes from the GermOnline database 
(Chalmel, Rolland et al. 2007, Gattiker, Niederhauser-Wiederkehr et al. 2007). 
157 of these genes were found to be differentially expressed in testes (Chalmel, 
Rolland et al. 2007). 139 of these genes were further clustered as “post-meiotic”, 
but only 6 as “meiotic”, 6 as “mitotic” and 6 as “somatic”. The rest 140 genes 
were not found in the dataset of differentially expressed testes specific genes as 
reported by Chalmel et al. 2007. Thus, 87% of the mis-expressed genes in the 
mutant that are also considered differentially expressed in testes according to the 
Germonline database are clustered as post-meiotic. This is clearly an over-
representation of post-meiotic genes, as only 20% of all the differentially 
expressed genes in the testes are clustered as post-meiotic in the Germonline 
database (Fig 3.3) (Chalmel, Rolland et al. 2007).  Further, as depicted in the 
heat map of the expression data (Fig 3.2) almost all under-expressed genes from 
our experiment show high expression in the post-meiotic spermatids, and almost 
no expression in spermatogonia. Transcripts of some of these genes are present 
in spermatocytes, but most are exclusively post-meiotic.  This suggests that 
BRWD1 predominantly regulates certain aspects of post-meiotic germ cell 
differentiation.  
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 Fig 3.3 Characterization of the Genes Regulated by BRWD1 A. Heat Map shows the expression pattern of 
the mis-regulated genes across three cell-types: Spermatogonia, Spermatocytes and Spermatids. Level of 
Expression denoted by color, with bright green indicating no to low level of expression to bright red stand-
ing for high levels of expression.  B. 1. Classi!cation of the mis-regulated genes as meiotic, mitotic, somatic 
or post-meiotic based on data from GermOnline database. 2. Classi!cation of all testis-speci!c transcripts on 
GermOnline Database for comparison.
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Production of Antibodies to BRWD1 
A previous post-doc (Dr. Dana Philipps) in my lab had collected antibody-rich 
serum and yolk from chicken injected with an antigenic C-terminal epitope of 
BRWD1. I purified this serum using Eggcellent Chicken IgY Purification kit as 
described in the methods section. I tested the specificity and activity of the 
purified antibody by a dot blot assay to the C-terminal peptide also described in 
the methods section. Reactivity of the purified antibodies was also tested for 
using a Western Blot assay of testes protein extracts. Brwd1-/- testes protein 
extracts served as negative controls. In spite of specific activity toward the C-
terminal epitope in the dot blot assay, the purified antibody failed to recognize 
BRWD1 specifically in the Western Blot. There was a strong signal in the blot 
around the expected size of 250 kDa but it was also found in the Brwd1-/- lane, 
indicating that this band was non-specifc. A commercially available BRWD1 
antibody from IMGENEX also did not recognize BRWD1 specifically. 
 
As a specific antibody to BRWD1 was vital to our studies, I decided to re-make 
antibodies to three different antigenic epitopes of BRWD1 as determined by an 
online software - PROTEAN tool. I tested the activities of these new antibodies 
using dot blot and the Western Blot assays as described above. Again, all three 
antibodies did not show specific BRWD1 binding. 
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BAC recombineering to generate TAP tagged Brwd1 transgenic mice. 
I used a well established protocol by Dr. Soren Warming that uses galK 
positive/counter-selection cassette (Warming, Costantino et al. 2005). In this 
method, the galK cassette is first inserted into the position in the gene in the 
BAC, where the tag must be inserted using a modified bacterial strain (SW102) 
that does not contain the galK cassette. The cassette is inserted at the precise 
position by flanking it with 400bp homology arms. The bacteria are then grown in 
media that contain galactose as the only carbon source, as a result of which, only 
those with a galK cassette survive. Furthermore these colonies appear pink in 
the medium of choice that is described by Dr. Warming. The pink colonies are 
subjected to another round of recombineering, this time using the TAP-tag with 
the same exact homology arms. This replaces the galK cassette in the bacteria. 
The bacteria are then grown on DOG medium; DOG is a harmless carbon 
source, unless phosphorylated by a functional galK, which turns into a toxic 
metabolite. Thus only bacteria that have successfully recombineered the TAP-tag 
will survive.  
In this experiment, I was able to recombineer the galK cassette into the SW102 
strain containing the BAC. However, many attempts to recombineer the TAP-tag 
into the galk-SW102 remained unfruitful. I decided to stop trouble-shooting this 
set of experiments, when a commercial FLAG-tagged pDREAM2.1(CMV)BRWD1 
plasmid became available. 
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Creating Transgenic Mice using pDREAM2.1FLAG-taggedBRWD1 
I then used the commercially available construct of FLAG-taggedBRWD1 for 
preparing transgenic mice. I first cloned the promoter of tcp10 gene upstream of 
the Flag-Brwd1 gene in pdream2.1 vector replacing the CMV promoter. This 
promoter has been shown to drive male germ-line specific expression of genes, 
specifically during the pachytene stage (Ewulonu, Buratynski et al. 1993). I 
prepared transgenic mice using both pronuclear injection and ES cell injection 
methods. These methods are described in detail in Chapter 2. 
 
From the pronuclear injection experiments, I obtained one male founder pup that 
had a successful integration of the transgene (out of 16 pups). This male was 
later out-bred to WT C3H females. From these females, he sired 26 pups. 12 out 
of 26 pups were positive for the transgene (~50%). I culled these mice at 35 days 
post partum (adult stage) and prepared protein extracts from their testes. I 
checked for expression of FLAG-BRWD1 in these mice by a Western Blot Assay 
and RT-PCR. None of the mice carrying the transgene expressed the tagged 
gene in the testes.  
 
For the ES cell transfection method, I linearized the pdream2.1(tcp10)FlagBrwd1 
plasmid into a fragment that contained the (tcp10)FlagBRWD1 along with 
neomycin cassette. I transfected this fragment into ES cells, and grew them 
under neomycin resistance to select for clones that had successfully integrated 
the transgene cassette. I was able to isolate 54 positive clones successfully. I 
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chose 20 clones at random and karyotyped them to check for any visible 
chromosomal defects. None of the clones had any defects. Out of these 20 
clones, I chose 3 clones at random (C1, A8 and B5) and injected them into 
blastocyst stage embryos. A work-sheet of the number of embryos injected and 
transferred, as well as the number of pups born from each round of injection is 
shown in Table 3.2. In the end, I had 5 chimeras, 4 male and 1 female. The 
percentage chimerism is indicated in Table 3.2.  None of the chimeras 
successfully transmitted the transgene in the germline. The female chimera was 
infertile and did not sire any offspring.  
 
Table 3.2 Worksheet of Production of Transgenic Mice 
Colony 
Injected 
 
BRWD1C1 BRWD1A8 BRWD1B5 
Embryos 
Transferred 
 
37 35 40 
Recipient 
Animals 
 
3 2 2 
Pups Born 
 
3 5 0 
Number of 
Chimeras 
and % 
Chimerism 
 
1 chimeric 
pup with 40% 
chimerism 
4 chimeric 
with 40-50% 
chimerism 
0 
Germline 
Transmission 
No No N/A 
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Expression and Subcellular Localization of FLAG tagged BRWD1 
Previous work has shown that Brwd1 is transcribed in a variety of tissues and 
cell types, including brain, kidney, testis, pancreas, muscle, ovary, developing 
embryo and dividing cell lines (Huang, Rambaldi et al. 2003). In order to 
determine which cell types in the testes express Brwd1, RNA in situ hybridization 
was performed to cross-sections of seminiferous tubules. Brwd1 transcripts were 
seen in spermatocytes and round spermatids (Fig 3.4) 
 
Attempts to produce specific antibodies to BRWD1 failed, so I generated a 
plasmid construct containing full-length BRWD1 with an N-terminal FLAG tag. 
Following transfection of this expression construct into HEK cells, a clear nuclear 
localization was observed (Fig 3.4). Cytoplasmic, nucleoplasmic and chromatin 
fractions were prepared from the cells that expressed FLAG-BRWD1 using a 
subcellular fractionation protocol as described by Mendez and Stillman et al. 
(Mendez and Stillman 2000). These protein fractions were then run on a 
polyacrylamide gel and transferred onto a Western Blot. When the blot was 
probed using an anti-FLAG antibody, FLAG-BRWD1 was found only in the 
chromatin-bound fraction. Actin served as a negative control for chromatin-bound 
proteins, and was found only in the cytoplasmic and nucleoplasmic fractions. 
Fibrillarin on the other hand served as a positive control, and was found in both 
nucleoplasmic as well as chromatin bound fractions, as expected (Reimer, 
Pollard et al. 1987). There is the possibility that FLAG-BRWD1 is insoluble and 
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precipitates along with the chromatin fraction, especially under conditions that 
over-express the protein causing it to aggregate or mis-fold.  I do not see any 
easily identifiable aggregate formation, however, in our immuno-stained cells that 
express FLAG-BRWD1. 
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Fig 3.4 A. In-situ hybridization reveals Brwd1 expression in spermatocytes and spermatids. B FLAG BRWD1 
transiently expressed in HEK cells - a predominantly nuclear localization was observed in the nucleus. C. 
Flag-BRWD1 was also found exclusively in the chromatin fraction in a sub-cellular fractionation experi-
ment. A cytoplasmic marker, actin and a nuclear marker !brillarin were used as positive controls for the 
fractionation experiment.
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In a separate experiment I tried to express FLAG-BRWD1 protein in oocytes 
to see where they localized. I expressed Flag-Brwd1 mRNA, which I then micro-
injected into the oocytes. The figure shows mRNA transcribed and poly-
adenylated in-vitro. I then stained the oocytes with an anti-Flag antibody to look 
for expression of protein, but I was never able to detect any expression. This 
maybe because of many reasons, three potential reasons I have listed below: 
1. Transcribed Flag-Brwd1 was not of quality good enough for translation.  
2. Brwd1 is at least 8 kb long, making it more susceptible for degradation 
by RNAses. 
3. Amount of RNA injected into the oocytes was not ideal.  
 
 
 
BRWD1 deficiency does not cause gross disruption of the spermatid 
epigenetic landscape. 
Epigenetic modifications of histones are central to transcriptional regulation, and 
the process of spermatogenesis occurs in the context of dramatic and wholesale 
chromatin remodeling (Hermo, Pelletier et al. 2010). Different nuclear domains 
are thought to exist within the round spermatid nucleus that can be distinguished 
by their unique epigenetic marks.  Any defects in the distribution of these marks 
and formation of these nuclear domains may cause transcriptional mis-regulation 
in spermatids. Both Brdt and Tlf mutants show dramatic chromatin-architecture 
defects in spermatids that are associated with mis-regulated expression of genes 
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(Martianov, Brancorsini et al. 2002, Shang, Nickerson et al. 2007, Berkovits and 
Wolgemuth 2011). In both mutants, the chromocenter (the nuclear structure that 
contains peri-centric heterochromatin in round spermatids) is fragmented and 
spermatid elongation is affected.  When the testis-specific demethylase JMJD1A 
is deleted, increased H3K9 mono- and di-methylation is seen by immunostaining 
in spermatids, and recruitment of CREM to the promoters of the protamine genes 
is affected, causing the spermatids to arrest in spermiogenesis. (Liu, Zhou et al. 
2010). Thus, the reduced expression of genes in Brwd1-/- mutants may be due to 
disrupted global chromatin architecture or distribution of epigenetic marks.  
 
To see if the global chromatin architecture is disrupted in spermatids in the 
Brwd1-/- mutants, I stained mutant spermatids with a number of epigenetic marks 
and chromatin associated proteins and looked for any dramatic differences from 
WT spermatids. I found that the chromocenter structure was preserved in the 
mutants as seen by staining for HP1alpha (Fig 3.5). I also found no major 
differences in the distribution of epigenetic marks between the Brwd1-/- 
spermatids and WT spermatids. No discernable differences were found in the 
distribution or intensity of staining of the transcription factors TBP and TLF. Thus, 
the extensive transcriptional mis-regulation observed in the mutants is not a 
result of gross defects in the chromatin architecture, or due to the altered 
distribution of epigenetic marks or transcriptional factors within global nuclear 
domains of spermatids. BRWD1 may however affect chromatin architecture 
around specific promoter sequences, and further studies are being undertaken to 
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test this hypothesis. Specifically, any altered epigenetic landscape around 
specific promoter sequences in the mutants can be discovered using ChIP-seq 
analyses of histone marks. I will be looking at the well-known epigenetic marks 
H3K4Me1, H3K4Me2 and H3K27Ac in the mutant mice to being with for any 
altered distribution around promoter sequences of post-meiotic genes.  
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Fig 3.5 Staining for Epigenetic Marks and some chromatin associated proteins do not reveal any 
di"erences in their distribution between WT and mutant.  This indicates that nuclear domains 
that are formed in spermatids are una"ected in the mutant. Global chromatin structures remain 
unaltered.
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Preliminary Studies on Local Chromatin Architecture 
As Brwd1 deficiency did not affect global chromatin architecture, I attempted to 
look at local chromatin architecture around genes that were affected in the 
mutant. In particular, I chose to work with the “protamine domain” that contained 
a cluster of genes Prm1, Prm2, Prm3 and Tnp2, all of which were under-
expressed in the mutant. The chromatin architecture changes that take place in 
the protamine domain have been characterized as spermatocytes differentiate 
into spermatids (Martins and Krawetz 2007).  Expression of all four genes in the 
“protamine domain” was affected in the mutant. One possible reason for this is 
that the chromatin around these genes has not become “potentiated” or ready for 
transcription to take place. Two signs of “potentiated” chromatin permissible for 
active transcription are  
i. “open” chromatin architecture with lesser higher order structures; 
making it “hypersensitive” to Dnase I  
ii. gain of epigenetic marks that are permissible to transcriptional 
activation. (Martins and Krawetz 2007) 
 
In my first set of experiments, I attempted to compare the DNAse I 
hypersensitivity of chromatin containing the “protamine” domain of Brwd1 
mutants with WT configuration in spermatids. In my second set of experiments I 
looked for any changes in localized epigenetic marks in Brwd1 deficient 
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spermatids that may explain the differences in expression of the genes in 
protamine domain in the mutant. 
 
After several rounds of trouble-shooting with a single cell suspension prepared 
from mouse testes, I decided to do the assay using the protocol described by 
Sambrook and Russell 2006. After digesting the chromatin with DNase I, I 
attempted to quantify the index of hypersensitivity using a real-time PCR assay. 
Briefly, I designed primers to amplify across a hypersensitive site in the 
protamine domain and an actin gene site (which served as control). The more 
hypersensitive the site is, the more it is digested by Dnase I, thereby reducing 
template available for amplification. The Ct values of the real-time PCR products, 
therefore, increase with increasing hypersensitivity. To be able to compare the 
hypersensitivity of a site, however I need to choose a concentration of Dnase I 
that is not too high; for otherwise the chromatin maybe completely digested 
whether the site is hypersensitive or not. To figure out the ideal concentration of 
Dnase I, I did a serial dilution of Dnase I and digested aliquots of chromatin with 
it, as described in the methods section. I then did a real-time PCR assay for 
protamine as well as actin hypersensitive sites across all the different enzyme 
concentrations. Plotting Ct versus Dnase I concentration would result in a linear 
graph. I calculated the index of Dnase I sensitivity as 2%Ct protamine / 2%Ct actin, 
where %Ct = Ct at mid-point of linear portion of graph – Ct of untreated 
chromatin. I was never able to get consistently increasing Ct values for either the 
actin hypersensitive site or the protamine site. After trying to trouble shoot for a 
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while, I stopped doing the experiment. The most likely explanation for getting 
inconsistent Ct values with increasing Dnase I activity is possibly due to variation 
in DNA preparation. Especially because very small quantities of DNA involved, 
even small variations in DNA preparation are reflected in real-time PCR.  
 
In order to compare the epigenetic profile of the protamine domain of mutant 
spermatids vs WT spermatids, I decided to do a ChIP assay for the epigenetic 
marks H4K16Ac, H3K9Me2 and H3K9/14Ac. I chose these histone marks 
because the way they change has been well documented for the protamine 
domain (Martins and Krawetz 2007). I found some differences in the regions that 
I tested between WT and mutant that I have documented in the table below. 
However, this experiment has not been replicated mainly because of the nature 
of germ-cell separation protocol – which is tedious and involves a lot of mice. I 
decided it maybe easier to do ChIP-seq, instead of individual PCRs. I did a 
preliminary ChIP-seq trial with these marks, but I was not able to find any 
discernable differences between WT and mutant in the profiling of these marks.  
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Redundant Functions of the BRWD family of Proteins 
 Though Brwd1 is expressed in a wide variety of tissues both in adult mice 
as well as developing embryos, Brwd1 mutants have no obvious defects other 
than infertility (Ramos, Vidal-Taboada et al. 2002, Huang, Rambaldi et al. 2003, 
Philipps, Wigglesworth et al. 2008). Brwd1 has two highly similar paralogs, Phip 
and Brwd3 that are also expressed in tissues expressing Brwd1. These genes 
are about 62% identical and 73% similar, raising the possibility that there is some 
level of functional redundancy within the family (Philipps, Wigglesworth et al. 
2008).  To test this hypothesis, we attempted to generate mice deficient for both 
Brwd1 and Phip. We were unable to create a Brwd3 mutant as the gene is X-
linked and the chimeric mice that we created were not able to transmit the Brwd3 
gene-trap through the germ line. One possibility maybe that BRWD3 is important 
for fertility of male mice rendering all germ cells that inherited the mutant allele 
infertile. The other possibility is that the chimeras that were created did not inherit 
the Brwd3 mutant allele in the germline and therefore none of the progeny 
carried the mutant allele. Mutation of Phip alone causes semi-lethality prenatally, 
and survivors were runted and typically died before puberty (Li et al, 2010).  
 
 I was unable to identify any double mutant offspring from 167 pups genotyped at 
weanage and 354 pups genotyped at 2 days after birth from crosses between 
double heterozygotes.  Surprisingly I found that Brwd1-/- mutants became semi-
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lethal in the mixed backgrounds contributed by the parental strains (containing 
C3H,129, and C57BL/6), indicating that BRWD1 had important functions in the 
soma as well.  
 To explore when embryos were being lost during development, I 
genotyped 12.5 day old embryos from timed matings between Brwd1+/- Phip+/- 
parents. Embryos of the doubly mutant genotype (Phip-/- Brwd1-/-) are 
indistinguishable from their siblings at this age. At E18.5, doubly mutant embryos 
were still alive and indistinguishable in appearance from Phip-/- embryos. The 
Phip-/- mutants at this stage were smaller than their WT or Brwd1-/- siblings, as 
expected (Fig 3.6). I also found one doubly mutant pup that was born dead or 
died shortly after birth. 
 
!
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Brwd1+/-Phip+/- Brwd1+/-Phip-/- Brwd1-/-Phip+/- Brwd1-/-Phip-/-
Brwd1+/-Phip+/- Brwd1+/-Phip-/- Brwd1-/-Phip+/- Brwd1-/-Phip-/-
12.5 day 
embryos
18.5 day
embryos
Fig 3.6 Comparison of embryos that are doubly mutant for Brwd1 and Phip. On both 12.5 days 
and 18.5 days post coitum, the doubly mutant embryos did not display a more severe pheno-
type than either of the single mutants.
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Table 3.3 Results of Phip+/-;Brwd+/- X Phip+/-;Brwd1+/- (at wean-age) 
 
        
 
 
 
 
                       
 
Total = 167 mice genotyped at wean-age. 
 
 
 
 
Table 1.2 Brwd1 mutants are semi-lethal in a mixed C3H-B6-129 background. 
                
 
 
 
     
 
 
                    Total = 161 mice genotyped at wean-age. 
 
Table 1.3 Results of Phip+/-;Brwd+/- X Phip+/-;Brwd1+/- (2 days after birth) 
 
 
 
 
 
 
 
 
 
 
                         Total = 354 mice genotyped at 2 days of age. 
 
  
Phip Genotype 
 +/+ +/- -/- 
+/+ 19 34 2 
+/- 38 51 4 
-/- 9 10 0 
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Brwd1 Genotype  
 +/+ +/- -/- 
Observed 53 89 19 
Expected 40.25 80.5 40.25 
Phip Genotype 
 +/+ +/- -/- 
+/+ 30 78 4 
+/- 64 101 5 
-/- 26 45 0 B
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CHAPTER 4 
 
DISCUSSION 
 
Drastic decreases in expression of critical post-meiotic genes are the likely 
cause of defective spermiogenesis in Brwd1-/- male mice. 
Around 300 genes show mis-regulated expression in Brwd1-/- mutants. GO 
(Gene Ontology) analysis of the misexpressed genes using the online tool 
DAVID shows that the most significant functional cluster (enrichment score = 6) 
is the process of spermatogenesis. Other significant functional clusters include 
genes involved in cytoskeletal dynamics, flagellum formation, chromatin 
organization, sperm motility, protein dynamics, and metabolic pathways. As 
about 80% of these genes are classified as post-meiotic by GermOnline, they 
may function in events that occur during spermiogenesis such as nucleosome 
remodeling, tail and head formation, cytoplasm extrusion, metabolic pathways 
important for sperm motility and survival, as well as regulation of expression of 
post-meiotic proteins.  Indeed, mouse knock-outs of 15 of these genes have 
been made and they display male sterility or reduced fertility because of 
defective spermiogenesis (Table 4.1). Four of the most dramatically under-
expressed genes (about 16-30 fold down-regulated) - Tnp2, Tssk6, Prm2 and 
Tnp1 - are important for the process of histone to protamine transition that occurs 
during spermiogenesis. Mouse mutants of these genes display abnormal sperm 
head shapes and defective chromatin condensation similar to Brwd1-/- sperm (Yu, 
Zhang et al. 2000, Cho, Willis et al. 2001, Zhao, Shirley et al. 2001, Philipps, 
Wigglesworth et al. 2008). Mutants of the mis-expressed genes Akap4, 
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Calreticulin 3, Atp1a4, Pldi, Gapdhs and Herk4 display impaired sperm motility as 
does Brwd1-/- sperm (Miki, Qu et al. 2004, Huang, Somanath et al. 2005, 
Rodriguez and Stewart 2007, Heinen, Staubach et al. 2009, Ikawa, Tokuhiro et 
al. 2011, Jimenez, Sanchez et al. 2012). Other genes such as Odf1 and Oaz3 
are important for head-flagellum attachment (Tokuhiro, Isotani et al. 2009, Yang, 
Meinhardt et al. 2012). The extent of down-regulation of the above genes is 
indicated in Table 4.1. Thus a severe shortage of these genes’ protein products 
is probably responsible for the defective spermiogenesis and infertility in the 
Brwd1-/- mutants. 
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Table 4.1 List of Mis-expressed Genes that have been knocked-out previously 
 
S. 
No.  
Gene Fold-
Misregulated 
log2(mut/het) 
Phenotype  Reference 
1 Tnp2 -4.26 Reduced fertility and some 
morphological defects in sperm. KO 
(Zhao, Shirley et al. 
2001) 
2 Tssk6 -4.19 KO, male sterility, impairment in 
motility and sperm morphology, 
DNA condensation impaired in 
spermatids. 
(Spiridonov, Wong 
et al. 2005) 
3 Prm2 -4.18 Male Infertility, variety of abnormal 
sperm heads, lower motility, 
haploinsufficiency seen in chimeras 
transmitting germ cells that were 
heterozygous for Prm2 
(Cho, Willis et al. 
2001) 
4 Tnp1 -3.32 Reduced Fertility and defects in 
sperm condensation. KO 
(Yu, Zhang et al. 
2000) 
5 Akap
4 
-2.39 Knockout is infertile. Sperm motility 
disrupted and fibrous sheath 
disrupted, knockout 
(Huang, Somanath 
et al. 2005) 
6 Tssk2 -2.28 Male infertility, Failure to form 
elongated spermatids, apoptosis of 
spermatocytes and spermatids, 
appearance of round cells in the 
epididymal lumen 
(Xu, Hao et al. 
2008) 
7 H1fnt -2.14 Mutant mice were infertile. Shape 
and function of sperm were 
abnormal.  
(Tanaka, Matsuoka 
et al. 2006) 
8 Calret
iculin
3 
-2.10 Produced normal looking sperm but 
were infertile due to defective 
sperm migration from uterus into 
oviduct and defective binding to 
Zona Pellucida, KO  
(Ikawa, Tokuhiro et 
al. 2011) 
9 Oaz3 -2.07 Detached flagellum 
impaired acrosome reaction 
male infertility 
KO 
(Tokuhiro, Isotani 
et al. 2009) 
10 Atp1a
4 
-2.00 KO is infertile, sperm motility 
affected. 
(Jimenez, Sanchez 
et al. 2012) 
11 Pidi -1.94 Reduced testis weight and lower 
sperm motility, knockout  
(Heinen, Staubach 
et al. 2009) 
12 Gapd
hs 
-1.92 KO is Infertile and sperm motility is 
sluggish. 
(Miki, Qu et al. 
2004) 
13 Lipe -1.88 Low sperm count (Osuga, Ishibashi 
et al. 2000) 
14 Odf1 -1.78 Infertile, sperm head is detached. 
KO 
(Yang, Meinhardt et 
al. 2012) 
15 Herc4 -1.59 KO, reduced male fertility, kinked 
tail with cytoplasmic droplet, 
reduced sperm motility. 
(Rodriguez and 
Stewart 2007) 
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The CREM-tau ACT pathway has been shown to regulate expression of post-
meiotic genes important for spermiogenesis (Blendy, Kaestner et al. 1996, 
Krausz and Sassone-Corsi 2005, Sassone-Corsi 2005, Martianov, Choukrallah et 
al. 2010, Kosir, Juvan et al. 2012).  In Crem knock-out mice, close to 5000 genes 
are deregulated in the testes, 2000 of which were down-regulated and 3000 were 
up-regulated (Kosir, Juvan et al. 2012). , About 50% of the genes (~111 genes) 
that are mis-expressed in the Brwd1-/- mice are also mis-regulated in the CREM 
knock-out. Brwd1, however, is not mis-regulated in the CREM knock out. CREM-
tau and BRWD1 may function in the same pathway to regulate these genes, but 
we can also imagine scenarios where they may be working independently. More 
studies are needed to test these possibilities. Crem knockouts also have a more 
severe male infertility phenotype as mutant spermatids arrest before 
spermiogenesis is complete. This may be attributable to the larger number of 
misregulated genes in Crem mutants. The 50% of the genes down-regulated in 
the Brwd1 but not Crem mutants implicate more than one pathway for post-
meiotic gene regulation. 
 
My experiments showed that FLAG-BRWD1 tends to associate with chromatin 
when expressed in HEK cells. If it functions similarly in round spermatids we can 
think of a scenario where BRWD1, by virtue of its bromodomains, binds 
acetylated lysine residues of histones found on the nucleosomes of post-meiotic 
genes, causing transcriptional activation. Indeed, the “protamine domain” 
comprising the clustered genes Prm1, Prm2, Prm3 and Tnp2  (all of which are 
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down-regulated in the mutant) progressively gain acetylated histone marks as the 
germ cells differentiate from spermatocytes to spermatids where they are 
expressed (Martins and Krawetz 2007). BRWD1 also has a poly-Q transcriptional 
activation domain that has been shown to activate luciferase expression in an in-
vitro assay (Huang, Rambaldi et al. 2003). The WD structures that are present in 
the BRWD1 protein may also enable it to interact with a wide-variety of 
transcription factors, nucleosome remodelers and other signaling proteins. We 
can imagine a transcriptional pathway where BRWD1 might be part of unique 
post-meiotic transcriptional-activator complexes that interact with acetylated 
histones around post-meiotic genes.  
 
Despite its role in proper expression of many postmeiotic genes, my data 
shows that BRWD1 is not involved in maintaining or forming the chromocenter or 
other nuclear domains marked by specific epigenetic marks in round spermatids, 
unlike BRDT or TRF2,. BRWD1 might function more locally on specific promoter 
sequences around post-meiotic genes. We are currently pursuing this hypothesis 
by looking for potential changes in localized epigenetic marks, in particular the 
well-studied H3K4Me1, H3K4Me3 and H3K27ac, in the mutants using ChIP-seq. 
 
Because of its role as a transcriptional regulator in the male germline, we 
hypothesized that BRWD1 maybe involved in transcriptional regulation important 
for oocyte maturation.  Indeed, in a transcription run-on assay performed in-vitro, 
Brwd1 mutant GV oocytes of the SN stage displayed abnormally elevated 
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transcription levels. A microarray comparing WT and mutant oocytes however did 
not show any differences in the transcript levels, in direct contradiction with the 
above observation. One possibility that can explain this contradiction is that the 
microarray probes only mRNA transcripts; and transcription of other elements 
such as small RNAs, retrotransposons, etc is unaccounted for. Another striking 
phenotype of Brwd1 deficient oocytes was the presence of extremely de-
condensed chromosomes during meiosis I especially during metaphase and 
anaphase stages. The mutant oocytes showed a wide variety of chromosomal 
defects including univalent chromosomes, anaphase bridges and chromatid 
breaks including the presence of single chromatids in a large number of mutant 
oocytes. Taken together, the chromosome condensation defects in meiosis and 
the potential genomic instability caused by aberrant retrotransposon expression, 
help explain the infertility phenotype observed in Brwd1 knockout oocytes. 
 
Non-Germline Functions of BRWD1 
Brwd1 is expressed in a wide variety of tissues in the developing mouse 
embryo as well as in the adult animal, however, mutant animals have no 
discernable phenotypes other than infertility (Ramos, Vidal-Taboada et al. 2002, 
Huang, Rambaldi et al. 2003, Philipps, Wigglesworth et al. 2008). This may be 
explained by the fact that Brwd1 may have redundant functions with two other 
highly similar paralogs, Phip and Brwd3, both of which are expressed in multiple 
tissues like Brwd1.  
 
! $,!
All of the somatic functions of Brwd1 in the mouse can only be determined by a 
complete simultaneous knock out of all three genes. Indeed, invertebrates have 
only one homolog of the Brwd family of genes and a null mutation of it causes 
early lethality in the embryonic stage in Drosophila (D'Costa, Reifegerste et al. 
2006). Not surprisingly, the brwd gene (dbrwd3) in Drosophila is expressed in a 
wide variety of tissues analagous to the mammalian homologs, including germ 
cells. However, the function of dbrwd3 in germ cells has not been determined 
yet, as all mutant alleles identified thus far are lethal. Like the mammalian brwd 
genes, dbrwd3 is nuclear in many cells and also associates with actively 
transcribing chromatin in the polytene chromosomes, and may potentially act as 
a transcriptional activator (D'Costa, Reifegerste et al. 2006). I also found that 
Brwd1 mutants become semi-lethal in a C57BL/6J-C3H-129 mixed mouse 
background, thus alluding to its role in somatic tissue.  
 
I created a Phip mutant that had a different, more severe phenotype than 
Brwd1 mutants as described in the literature review. I went on to create a double 
knock-out of Phip and Brwd1, but the double mutants did not show a more 
severe phenotype than the Phip mutant alone, indicating either that Brwd3 
maybe able to compensate for the loss of both Brwd1 and Phip or there are no 
redundant functions between Brwd1 and Phip. 
 
How and why a ubiquitously expressed gene such as Brwd1 has evolved a non-
redundant role in the mammalian germline is still unanswered. Brwd1 is not the 
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only gene that has testis-specific unique functions, Crem-tau is also expressed 
widely in the mouse; but a null mutant is only male-infertile. Also, many 
transcriptional factor paralogs are exclusively expressed in male or female germ-
line, including those of the ubiquitously expressed TBP-associated factors and 
TBP. Not only does it seem that mice prefer to maintain a unique set of 
transcription factors and regulators in the germline, but also other ubiquitously 
expressed metabolic genes have a germ-line specific isoform or paralog that is 
expressed. The germline is of special importance to the organism, 
understandably so, as it ensures the continuity of the species into the next 
generation. Importantly, the development of germline cells has several unique 
features that are not present in any other somatic tissue. Transcription occurs 
from haploid cells only in the germ-line. Only the germline undergoes meiosis. 
Both male and female germ cells undergo genome-wide transcriptional silencing 
and impressive chromatin re-modeling and packaging – therefore all protein 
products required for processes that occur after transcriptional silencing have to 
be expressed before-hand and translationally regulated. Many of the genes 
expressed in oocytes and spermatids are very unique and must be silenced in all 
other cell-types. Therefore it seems that the regulation of transcription in the 
germ-line poses a unique challenge to the organism due to a number of reasons, 
and it has evolved a separate set of regulators to deal with it. Brwd1, a 
ubiquitously expressed gene, might have co-evolved specific functions in the 
male and female germ-line along with these specialized factors.  
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CHAPTER 5 
 
CONCLUSIONS 
 
 
 
1. BRWD1 is important for genes expressed post-meiotically in the 
mammalian male germ-line. The genes that it regulates are important for 
the process of spermiogenesis by which round spermatids differentiate 
into sperm and a Brwd1 mutant is thus infertile due to defective 
spermiogenesis. 
2. Brwd1 is expressed in spermatocytes and spermatids in the male germ-
lin. When a construct containing FLAG-BRWD1 was transiently 
transfected into HEK cells, BRWD1 was found to be exclusively nuclear 
and bound to chromatin. 
3. Brwd1 deficiency does not cause fragmentation of the chromocenter, a 
heterochromatin structure found in spermatids nor does it affect the 
formation of nuclear domains characterized by unique epigenetic marks.  
4. BRWD1 has somatic functions that become non-redundant in certain 
mouse backgrounds. It also appears that Brwd1 does not have any 
redundant functions with Phip, as double mutant embryos do not look 
different from the singly mutant Phip. 
 
 
  
! ,&!
APPENDIX 
LIST OF GENES DOWN-REGULATED IN BRWD1 MUTANTS 
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